Nick C. Fox, MD - Publications

Affiliations: 
Dementia Research Centre, Institute of Neurology University College London, London, United Kingdom 
Area:
Neuroimaging, Dementia, Clinical Neurology
Website:
http://www.ucl.ac.uk/neuroscience/Page.php?ID=12&ResearcherID=193

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Iaccarino L, Llibre-Guerra JJ, McDade E, Edwards L, Gordon B, Benzinger T, Hassenstab J, Kramer JH, Li Y, Miller BL, Miller Z, Morris JC, Mundada N, Perrin RJ, Rosen HJ, ... ... Fox NC, et al. Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 6: fcae159. PMID 38784820 DOI: 10.1093/braincomms/fcae159  0.324
2024 Zarkali A, Hannaway N, McColgan P, Heslegrave AJ, Veleva E, Laban R, Zetterberg H, Lees AJ, Fox NC, Weil RS. Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes. Brain Communications. 6: fcae130. PMID 38715714 DOI: 10.1093/braincomms/fcae130  0.301
2024 Keuss SE, Coath W, Cash DM, Barnes J, Nicholas JM, Lane CA, Parker TD, Keshavan A, Buchanan SM, Wagen AZ, Storey M, Harris M, Lu K, James SN, Street R, ... ... Fox NC, et al. Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 38199813 DOI: 10.1136/jnnp-2023-332067  0.339
2023 Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, Strom A, Gordon B, Mundada N, Schindler SE, Tsoy E, Ma Y, Lu R, Fagan AM, Benzinger TLS, ... ... Fox NC, et al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280. PMID 37942088 DOI: 10.1093/braincomms/fcad280  0.372
2023 Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, ... ... Fox NC, et al. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. Jama Neurology. PMID 37843849 DOI: 10.1001/jamaneurol.2023.3618  0.351
2023 McKay NS, Gordon BA, Hornbeck RC, Dincer A, Flores S, Keefe SJ, Joseph-Mathurin N, Jack CR, Koeppe R, Millar PR, Ances BM, Chen CD, Daniels A, Hobbs DA, Jackson K, ... ... Fox NC, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience. PMID 37429916 DOI: 10.1038/s41593-023-01359-8  0.332
2023 Schultz SA, Shirzadi Z, Schultz AP, Liu L, Fitzpatrick CD, McDade E, Barthelemy NR, Renton A, Esposito B, Joseph-Mathurin N, Cruchaga C, Chen CD, Goate A, Allegri RF, Benzinger TLS, ... ... Fox NC, et al. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871. PMID 37291760 DOI: 10.1111/acel.13871  0.322
2023 O'Connor A, Cash DM, Poole T, Markiewicz PJ, Fraser MR, Malone IB, Jiao J, Weston PSJ, Flores S, Hornbeck R, McDade E, Schöll M, Gordon BA, Bateman RJ, Benzinger TLS, ... Fox NC, et al. Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [F]flortaucipir study. Alzheimer's Research & Therapy. 15: 99. PMID 37231491 DOI: 10.1186/s13195-023-01234-5  0.341
2023 Green RE, Lord J, Scelsi MA, Xu J, Wong A, Naomi-James S, Handy A, Gilchrist L, Williams DM, Parker TD, Lane CA, Malone IB, Cash DM, Sudre CH, Coath W, ... ... Fox NC, et al. Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease. Alzheimer's Research & Therapy. 15: 38. PMID 36814324 DOI: 10.1186/s13195-023-01184-y  0.301
2023 Mead S, Fox NC. Lecanemab slows Alzheimer's disease: hope and challenges. The Lancet. Neurology. 22: 106-108. PMID 36681438 DOI: 10.1016/S1474-4422(22)00529-4  0.324
2022 Vöglein J, Franzmeier N, Morris JC, Dieterich M, McDade E, Simons M, Preische O, Hofmann A, Hassenstab J, Benzinger TL, Fagan A, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, ... ... Fox NC, et al. Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35609137 DOI: 10.1002/alz.12684  0.31
2022 Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, ... ... Fox NC, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181  0.4
2022 Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR, ... ... Fox NC, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics. PMID 35379992 DOI: 10.1038/s41588-022-01024-z  0.304
2022 Luckett PH, Chen C, Gordon BA, Wisch J, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, et al. Biomarker clustering in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35362200 DOI: 10.1002/alz.12661  0.31
2022 Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Fox NC, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6  0.346
2021 Hazan J, Alston D, Fox NC, Howard R. Practical application of Alzheimer's Disease Neuroimaging Initiative plasma P-tau181 reference data to support diagnosis of Alzheimer's disease. International Journal of Geriatric Psychiatry. 37. PMID 34997780 DOI: 10.1002/gps.5670  0.36
2021 Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, ... ... Fox NC, et al. Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. Neurology. 20: 895-906. PMID 34687634 DOI: 10.1016/S1474-4422(21)00263-5  0.316
2021 Alawode DOT, Heslegrave AJ, Ashton NJ, Karikari TK, Simrén J, Montoliu-Gaya L, Pannee J, O Connor A, Weston PSJ, Lantero-Rodriguez J, Keshavan A, Snellman A, Gobom J, Paterson RW, Schott JM, ... ... Fox NC, et al. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Journal of Internal Medicine. PMID 34021943 DOI: 10.1111/joim.13332  0.308
2021 Yap SY, Frias B, Wren MC, Schöll M, Fox NC, Årstad E, Lashley T, Sander K. Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease. Brain : a Journal of Neurology. PMID 33742656 DOI: 10.1093/brain/awab120  0.349
2021 Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, ... ... Fox NC, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112  0.346
2021 Lu K, Nicholas JM, Weston PSJ, Stout JC, O'Regan AM, James SN, Buchanan SM, Lane CA, Parker TD, Keuss SE, Keshavan A, Murray-Smith H, Cash DM, Sudre CH, Malone IB, ... ... Fox NC, et al. Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer's disease. Brain Communications. 3: fcab003. PMID 33615219 DOI: 10.1093/braincomms/fcab003  0.329
2021 Joseph-Mathurin N, Wang G, Kantarci K, Jack CR, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, ... ... Fox NC, et al. Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. PMID 33495373 DOI: 10.1212/WNL.0000000000011542  0.308
2021 Pemberton HG, Goodkin O, Prados F, Das RK, Vos SB, Moggridge J, Coath W, Gordon E, Barrett R, Schmitt A, Whiteley-Jones H, Burd C, Wattjes MP, Haller S, Vernooij MW, ... ... Fox NC, et al. Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study. European Radiology. PMID 33452627 DOI: 10.1007/s00330-020-07455-8  0.367
2020 Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, et al. BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain. Brain : a Journal of Neurology. PMID 33253354 DOI: 10.1093/brain/awaa332  0.332
2020 Pavisic IM, Nicholas JM, O'Connor A, Rice H, Lu K, Fox NC, Ryan NS. Disease duration in autosomal dominant familial Alzheimer disease: A survival analysis. Neurology. Genetics. 6: e507. PMID 33225064 DOI: 10.1212/Nxg.0000000000000507  0.387
2020 O'Connor A, Weston PSJ, Pavisic IM, Ryan NS, Collins JD, Lu K, Crutch SJ, Alexander DC, Fox NC, Oxtoby NP. Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer's disease: a retrospective cohort analysis. Alzheimer's Research & Therapy. 12: 126. PMID 33023653 DOI: 10.1186/s13195-020-00695-2  0.351
2020 Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease. Brain Communications. 2: fcaa102. PMID 32954344 DOI: 10.1093/braincomms/fcaa102  0.303
2020 Weston PSJ, Poole T, Nicholas JM, Toussaint N, Simpson IJA, Modat M, Ryan NS, Liang Y, Rossor MN, Schott JM, Ourselin S, Zhang H, Fox NC. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease. Alzheimer's Research & Therapy. 12: 112. PMID 32943095 DOI: 10.1186/S13195-020-00679-2  0.448
2020 Mason SA, Al Saikhan L, Jones S, Bale G, James SN, Murray-Smith H, Rapala A, Williams S, Wong B, Richards M, Fox NC, Hardy R, Schott JM, Chaturvedi N, Hughes AD. Study Protocol - Insight 46 Cardiovascular: A Sub-study of the MRC National Survey of Health and Development. Artery Research. 26: 170-179. PMID 32879639 DOI: 10.2991/Artres.K.200417.001  0.378
2020 Ball HA, McWhirter L, Ballard C, Bhome R, Blackburn DJ, Edwards MJ, Fleming SM, Fox NC, Howard R, Huntley J, Isaacs JD, Larner AJ, Nicholson TR, Pennington CM, Poole N, et al. Functional cognitive disorder: dementia's blind spot. Brain : a Journal of Neurology. PMID 32791521 DOI: 10.1093/Brain/Awaa224  0.351
2020 Lu K, Nicholas JM, James SN, Lane CA, Parker TD, Keshavan A, Keuss SE, Buchanan SM, Murray-Smith H, Cash DM, Sudre CH, Malone IB, Coath W, Wong A, Henley SMD, ... Fox NC, et al. Increased variability in reaction time is associated with amyloid beta pathology at age 70. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12076. PMID 32789161 DOI: 10.1002/Dad2.12076  0.334
2020 Chen Z, Yan Yau W, Jaunmuktane Z, Tucci A, Sivakumar P, Gagliano Taliun SA, Turner C, Efthymiou S, Ibáñez K, Sullivan R, Bibi F, Athanasiou-Fragkouli A, Bourinaris T, Zhang D, Revesz T, ... ... Fox NC, et al. Neuronal intranuclear inclusion disease is genetically heterogeneous. Annals of Clinical and Translational Neurology. PMID 32777174 DOI: 10.1002/Acn3.51151  0.345
2020 O'Connor A, Karikari TK, Poole T, Ashton NJ, Lantero Rodriguez J, Khatun A, Swift I, Heslegrave AJ, Abel E, Chung E, Weston PSJ, Pavisic IM, Ryan NS, Barker S, Rossor MN, ... ... Fox NC, et al. Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study. Molecular Psychiatry. PMID 32665603 DOI: 10.1038/S41380-020-0838-X  0.393
2020 Suárez-González A, Zimmermann N, Waddington C, Wood O, Harding E, Brotherhood E, Fox NC, Crutch SJ. Non-memory led dementias: care in the time of covid-19. Bmj (Clinical Research Ed.). 369: m2489. PMID 32606068 DOI: 10.1136/Bmj.M2489  0.352
2020 Buchanan SM, Parker TD, Lane CA, Keshavan A, Keuss SE, Lu K, James SN, Murray-Smith H, Wong A, Nicholas J, Cash DM, Malone IB, Coath W, Thomas DL, Sudre C, ... Fox NC, et al. Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort. Journal of Neurology. PMID 32583050 DOI: 10.1007/S00415-020-10004-4  0.325
2020 Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jiménez D, Betts MJ, McGlinchey E, Berron D, O'Connor A, Fox NC, Pereira JB, et al. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimer's Research & Therapy. 12: 49. PMID 32340618 DOI: 10.1186/S13195-020-00612-7  0.337
2020 Parker TD, Cash DM, Lane CA, Lu K, Malone IB, Nicholas JM, James SN, Keshavan A, Murray-Smith H, Wong A, Buchanan SM, Keuss SE, Sudre CH, Thomas DL, Crutch SJ, ... Fox NC, et al. Amyloid β influences the relationship between cortical thickness and vascular load. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12022. PMID 32313829 DOI: 10.1002/Dad2.12022  0.402
2020 Banerjee G, Ambler G, Keshavan A, Paterson RW, Foiani MS, Toombs J, Heslegrave A, Dickson JC, Fraioli F, Groves AM, Lunn MP, Fox NC, Zetterberg H, Schott JM, Werring DJ. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy. Journal of Alzheimer's Disease : Jad. PMID 32176643 DOI: 10.3233/Jad-191254  0.326
2020 Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, ... ... Fox NC, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z  0.422
2020 Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032  0.444
2019 Clarke MTM, Brinkmalm A, Foiani MS, Woollacott IOC, Heller C, Heslegrave A, Keshavan A, Fox NC, Schott JM, Warren JD, Blennow K, Zetterberg H, Rohrer JD. CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia. Alzheimer's Research & Therapy. 11: 105. PMID 31847891 DOI: 10.1186/S13195-019-0564-2  0.4
2019 Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. The Lancet. Neurology. PMID 31810826 DOI: 10.1016/S1474-4422(19)30394-1  0.349
2019 Parker T, Cash DM, Lane C, Lu K, Malone IB, Nicholas JM, James S, Keshavan A, Murray-Smith H, Wong A, Buchannan S, Keuss S, Sudre CH, Thomas D, Crutch S, ... ... Fox NC, et al. Pure tone audiometry and cerebral pathology in healthy older adults. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31699832 DOI: 10.1136/Jnnp-2019-321897  0.326
2019 Lu K, Nicholas JM, Collins JD, James SN, Parker TD, Lane CA, Keshavan A, Keuss SE, Buchanan SM, Murray-Smith H, Cash DM, Sudre CH, Malone IB, Coath W, Wong A, ... ... Fox NC, et al. Cognition at age 70: Life course predictors and associations with brain pathologies. Neurology. PMID 31666352 DOI: 10.1212/Wnl.0000000000008534  0.331
2019 Parker TD, Cash DM, Lane CAS, Lu K, Malone IB, Nicholas JM, James SN, Keshavan A, Murray-Smith H, Wong A, Buchanan SM, Keuss SE, Sudre CH, Modat M, Thomas DL, ... ... Fox NC, et al. Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946. Plos One. 14: e0224030. PMID 31622410 DOI: 10.1371/Journal.Pone.0224030  0.433
2019 Convery RS, Jiao J, Clarke MTM, Moore KM, Koriath CAM, Woollacott IOC, Weston PSJ, Gunn R, Rabiner I, Cash DM, Rossor MN, Warren JD, Fox NC, Ourselin S, Bocchetta M, et al. Longitudinal (F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31439620 DOI: 10.1136/Jnnp-2019-320904  0.365
2019 Mauricio R, Benn C, Davis J, Dawson G, Dawson LA, Evans A, Fox N, Gallacher J, Hutton M, Isaac J, Jones DNC, Jones L, Lalli G, Libri V, Lovestone S, et al. Tackling gaps in developing life-changing treatments for dementia. Alzheimer's & Dementia (New York, N. Y.). 5: 241-253. PMID 31297438 DOI: 10.1016/J.Trci.2019.05.001  0.353
2019 Paterson RW, Gabelle A, Lucey BP, Barthélemy NR, Leckey CA, Hirtz C, Lehmann S, Sato C, Patterson BW, West T, Yarasheski K, Rohrer JD, Wildburger NC, Schott JM, Karch CM, ... ... Fox NC, et al. SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases. Nature Reviews. Neurology. PMID 31222062 DOI: 10.1038/S41582-019-0222-0  0.399
2019 Firth NC, Primativo S, Marinescu RV, Shakespeare TJ, Suarez-Gonzalez A, Lehmann M, Carton A, Ocal D, Pavisic I, Paterson RW, Slattery CF, Foulkes AJM, Ridha BH, Gil-Néciga E, Oxtoby NP, ... ... Fox NC, et al. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy. Brain : a Journal of Neurology. PMID 31219516 DOI: 10.1093/Brain/Awz136  0.477
2019 Foiani MS, Cicognola C, Ermann N, Woollacott IOC, Heller C, Heslegrave AJ, Keshavan A, Paterson RW, Ye K, Kornhuber J, Fox NC, Schott JM, Warren JD, Lewczuk P, Zetterberg H, et al. Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30981993 DOI: 10.1136/Jnnp-2018-319266  0.411
2019 Arber C, Toombs J, Lovejoy CC, Ryan NS, Paterson RW, Willumsen N, Gkanatsiou E, Portelius E, Blennow K, Heslegrave A, Schott JM, Hardy J, Lashley T, Fox NC, Zetterberg H, et al. Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. Molecular Psychiatry. PMID 30980041 DOI: 10.1038/S41380-019-0410-8  0.363
2019 Koriath C, Lashley T, Taylor W, Druyeh R, Dimitriadis A, Denning N, Williams J, Warren JD, Fox NC, Schott JM, Rowe JB, Collinge J, Rohrer JD, Mead S. ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 277-280. PMID 30949567 DOI: 10.1016/J.Dadm.2019.01.010  0.428
2019 Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J, Hardy J, Escott-Price V. Polygenic risk and hazard scores for Alzheimer's disease prediction. Annals of Clinical and Translational Neurology. 6: 456-465. PMID 30911569 DOI: 10.1002/Acn3.716  0.376
2019 Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Fox N, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6  0.409
2019 Vöglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, Benzinger TL, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, Farlow MR, Chhatwal J, Salloway S, Xiong C, ... ... Fox N, et al. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30897203 DOI: 10.1093/Brain/Awz050  0.405
2019 Weston PSJ, Poole T, O'Connor A, Heslegrave A, Ryan NS, Liang Y, Druyeh R, Mead S, Blennow K, Schott JM, Frost C, Zetterberg H, Fox NC. Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease. Alzheimer's Research & Therapy. 11: 19. PMID 30786919 DOI: 10.1186/S13195-019-0472-5  0.392
2019 Schott JM, Aisen PS, Cummings JL, Howard RJ, Fox NC. Unsuccessful trials of therapies for Alzheimer's disease. Lancet (London, England). 393: 29. PMID 30614456 DOI: 10.1016/S0140-6736(18)31896-8  0.373
2019 Buchanan SM, Parker TD, Lane CA, Keshavan A, Keuss SE, Schrag AE, Fox NC, Richards M, Schott JM. 14.45 Relationships between walking speed, cognition & brain pathologies: an imaging study of the 1946 birth cohort Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.11  0.38
2019 James S, Lane C, Parker T, Lu K, Keshavan A, Buchanan S, Keuss S, Cash D, Malone I, Nicholas J, Murray-Smith H, Wong A, Fox N, Schott J, Richards M. P68 Divergent associations between life course cognitive trajectories and brain pathologies: findings from the 1946 british birth cohort Journal of Epidemiology and Community Health. 73. DOI: 10.1136/Jech-2019-Ssmabstracts.219  0.409
2019 Fox N. Imaging in dementia Journal of the Neurological Sciences. 405: 16-17. DOI: 10.1016/J.Jns.2019.10.044  0.329
2019 Leckey CA, Hällqvist J, Doykov ID, Mills K, Wray S, Fox NC, Zetterberg H, Paterson RW. P1-261: DEVELOPMENT OF A UNIFIED -OMIC PREPARATION METHODOLOGY: AN ALTERNATIVE, NON-IP APPROACH TO TARGETED LC-MS/MS DETECTION OF SECRETED AMYLOID-β PEPTIDES IN CEREBROSPINAL FLUID AND IPSC-DERIVED FAMILIAL ALZHEIMER'S DISEASE MODELS Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.816  0.319
2019 Lane CA, Barnes J, Nicholas JM, Parker TD, Keshavan A, Buchanan SM, Keuss SE, Sudre CH, Cash DM, Malone IB, James S, Wong A, Richards M, Fox NC, Schott JM. O4-13-01: Early Adulthood Vascular Risk Strongly Predicts Brain Volumes And White Matter Disease, But Not Amyloid Status, At Age 69-71 Years: Evidence From A British Birth Cohort Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4812  0.35
2019 Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mukai Y, Michelson D, Egan MF. O3‐10‐02: Verubecestat‐Induced Brain Volume Loss Occurs Rapidly And Only In Amyloid‐Enriched Brain Regions In Epoch, A Phase 3 Trial In Mild‐To‐Moderate Alzheimer'S Disease Patients Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4679  0.385
2019 James S, Lane CA, Parker TD, Lu K, Keshavan A, Buchanan SM, Keuss SE, Cash DM, Malone IB, Nicholas JM, Murray-Smith H, Wong A, Fox NC, Schott JM, Richards M. O3-03-04: Divergent Associations Between Life Course Cognitive Trajectories And Brain Pathologies: Findings From The 1946 British Birth Cohort Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4639  0.304
2019 O'Connor A, Oxtoby NP, Weston PS, Pavisic IM, Ryan NS, Lu K, Crutch SJ, Alexander DC, Fox NC. O3-03-01: The Sequence And Timing Of Preclinical Cognitive Decline In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4636  0.377
2019 O'Connor A, Markiewicz PJ, Cash DM, Schöll M, Weston PS, Ryan NS, Pavisic IM, Lu K, Fraser MR, Malone IB, Fox NC. O2-09-05: Longitudinal F-Av-1451 Tau Pet In Familial Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4503  0.359
2019 Ryan NS, Willumsen N, Walsh P, Fox NC, Lashley T. O2-08-04: Phenotypic Heterogeneity In Familial Alzheimer'S Disease And Associations With Cerebral Amyloid Angiopathy Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4496  0.408
2019 Weston PSJ, Toussaint N, Poole T, Simpson I, Nicholas JM, Lehmann M, Modat M, Daga P, Ryan NS, Liang Y, Rossor MN, Schott JM, Ourselin S, Zhang H, Fox NC. P3-419: Measuring Cortical Mean Diffusivity To Assess Early Microstructural Cortical Change In Presymptomatic Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3453  0.389
2019 Keshavan A, Lane CA, Parker TD, Lu K, Cash DM, Sudre CH, Nicholas JM, Heslegrave AJ, James S, Murray-Smith H, Buchanan SM, Keuss SE, Thomas DL, Malone IB, Wong A, ... ... Fox NC, et al. P3-234: Plasma Amyloid, Tau And Serum Neurofilament Light Chain In Insight 46: Associations With Cognition And Brain Imaging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3264  0.337
2018 Vöglein J, Noachtar S, McDade E, Quaid KA, Salloway S, Ghetti B, Noble J, Berman S, Chhatwal J, Mori H, Fox N, Allegri R, Masters CL, Buckles V, Ringman JM, et al. Seizures as an early symptom of autosomal dominant Alzheimer's disease. Neurobiology of Aging. 76: 18-23. PMID 30616208 DOI: 10.1016/J.Neurobiolaging.2018.11.022  0.309
2018 Parker TD, Slattery CF, Yong KXX, Nicholas JM, Paterson RW, Foulkes AJM, Malone IB, Thomas DL, Cash DM, Crutch SJ, Fox NC, Schott JM. Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease. Neuroimage. Clinical. 101632. PMID 30558867 DOI: 10.1016/J.Nicl.2018.101632  0.391
2018 Lynch DS, Wade C, Paiva ARB, John N, Kinsella JA, Merwick Á, Ahmed RM, Warren JD, Mummery CJ, Schott JM, Fox NC, Houlden H, Adams ME, Davagnanam I, Murphy E, et al. Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30467211 DOI: 10.1136/Jnnp-2018-319481  0.316
2018 Sánchez-Valle R, Heslegrave A, Foiani MS, Bosch B, Antonell A, Balasa M, Lladó A, Zetterberg H, Fox NC. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 10: 113. PMID 30390718 DOI: 10.1186/S13195-018-0439-Y  0.398
2018 Ten Kate M, Ingala S, Schwarz AJ, Fox NC, Chételat G, van Berckel BNM, Ewers M, Foley C, Gispert JD, Hill D, Irizarry MC, Lammertsma AA, Molinuevo JL, Ritchie C, Scheltens P, et al. Secondary prevention of Alzheimer's dementia: neuroimaging contributions. Alzheimer's Research & Therapy. 10: 112. PMID 30376881 DOI: 10.1186/S13195-018-0438-Z  0.439
2018 Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, ... ... Fox NC, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nature Communications. 9: 4273. PMID 30323170 DOI: 10.1038/S41467-018-05892-0  0.431
2018 Koriath C, Kenny J, Adamson G, Druyeh R, Taylor W, Beck J, Quinn L, Mok TH, Dimitriadis A, Norsworthy P, Bass N, Carter J, Walker Z, Kipps C, Coulthard E, ... ... Fox NC, et al. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Molecular Psychiatry. PMID 30279455 DOI: 10.1038/S41380-018-0224-0  0.346
2018 Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, ... Fox NC, et al. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Annals of Neurology. PMID 30255971 DOI: 10.1002/Ana.25333  0.332
2018 Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, ... ... Fox NC, et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30239611 DOI: 10.1093/Brain/Awy229  0.432
2018 McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, ... ... Fox NC, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277  0.453
2018 Woollacott IOC, Bocchetta M, Sudre CH, Ridha BH, Strand C, Courtney R, Ourselin S, Cardoso MJ, Warren JD, Rossor MN, Revesz T, Fox NC, Holton JL, Lashley T, Rohrer JD. Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia. Neurocase. 1-9. PMID 30112957 DOI: 10.1080/13554794.2018.1506039  0.371
2018 Woollacott IOC, Nicholas JM, Heslegrave A, Heller C, Foiani MS, Dick KM, Russell LL, Paterson RW, Keshavan A, Fox NC, Warren JD, Schott JM, Zetterberg H, Rohrer JD. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimer's Research & Therapy. 10: 79. PMID 30111356 DOI: 10.1186/S13195-018-0405-8  0.417
2018 Santos M, Osório E, Finnegan S, Clarkson M, Timóteo S, Brandão I, Roma-Torres A, Fox NC, Bastos-Leite AJ. Registration-based methods applied to serial high-resolution T1-weighted magnetic resonance imaging for the assessment of brain volume changes in anorexia nervosa of the restricting type. Psychiatry Research. Neuroimaging. 279: 14-18. PMID 30075347 DOI: 10.1016/J.Pscychresns.2018.06.014  0.332
2018 Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, et al. Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease. Alzheimer's Research & Therapy. 10: 73. PMID 30060761 DOI: 10.1186/S13195-018-0372-0  0.325
2018 Salloway SP, Sperling R, Fox NC, Sabbagh MN, Honig LS, Porsteinsson AP, Rofael H, Ketter N, Wang D, Liu E, Carr S, Black RS, Brashear HR. Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study. Journal of Alzheimer's Disease : Jad. PMID 29914022 DOI: 10.3233/Jad-171157  0.406
2018 Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838  0.453
2018 Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Fox NC, Schott JM, Alexander DC. Data-driven models of dominantly-inherited Alzheimer's disease progression. Brain : a Journal of Neurology. PMID 29579160 DOI: 10.1093/Brain/Awy050  0.437
2018 Parker TD, Slattery CF, Zhang J, Nicholas JM, Paterson RW, Foulkes AJM, Malone IB, Thomas DL, Modat M, Cash DM, Crutch SJ, Alexander DC, Ourselin S, Fox NC, Zhang H, et al. Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging. Human Brain Mapping. PMID 29575324 DOI: 10.1002/Hbm.24056  0.402
2018 Paterson RW, Slattery CF, Poole T, Nicholas JM, Magdalinou NK, Toombs J, Chapman MD, Lunn MP, Heslegrave AJ, Foiani MS, Weston PSJ, Keshavan A, Rohrer JD, Rossor MN, Warren JD, ... ... Fox NC, et al. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimer's Research & Therapy. 10: 32. PMID 29558979 DOI: 10.1186/S13195-018-0361-3  0.446
2018 Wellington H, Paterson RW, Suárez-González A, Poole T, Frost C, Sjöbom U, Slattery CF, Magdalinou NK, Lehmann M, Portelius E, Fox NC, Blennow K, Zetterberg H, Schott JM. CSF neurogranin or tau distinguish typical and atypical Alzheimer disease. Annals of Clinical and Translational Neurology. 5: 162-171. PMID 29468177 DOI: 10.1002/Acn3.518  0.44
2018 Foiani MS, Woollacott IO, Heller C, Bocchetta M, Heslegrave A, Dick KM, Russell LL, Marshall CR, Mead S, Schott JM, Fox NC, Warren JD, Zetterberg H, Rohrer JD. Plasma tau is increased in frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29440230 DOI: 10.1136/Jnnp-2017-317260  0.388
2018 Weston PSJ, Nicholas JM, Henley SMD, Liang Y, Macpherson K, Donnachie E, Schott JM, Rossor MN, Crutch SJ, Butler CR, Zeman AZ, Fox NC. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 17: 123-132. PMID 29413314 DOI: 10.1016/S1474-4422(17)30434-9  0.392
2018 Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, ... ... Fox NC, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0  0.469
2018 Marshall CR, Hardy CJD, Volkmer A, Russell LL, Bond RL, Fletcher PD, Clark CN, Mummery CJ, Schott JM, Rossor MN, Fox NC, Crutch SJ, Rohrer JD, Warren JD. Primary progressive aphasia: a clinical approach. Journal of Neurology. PMID 29392464 DOI: 10.1007/S00415-018-8762-6  0.328
2018 Parker TD, Slattery CF, Zhang J, Nicholas JM, Paterson RW, Foulkes AJ, Keuss SE, Malone IB, Thomas DL, Modat M, Cash DM, Crutch SJ, Yong K, Alexander DC, Ourselin S, ... Fox NC, et al. P1-474: Surface-Based Analysis Of Cortical Grey Matter Microstructure In Young-Onset Alzheimer'S Disease Using Neurite Orientation Dispersion And Density Imaging (Noddi) Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.484  0.399
2018 Sánchez-Valle R, Heslegrave A, Foiani MS, Bosch B, Antonell A, Balasa M, Lladó A, Zetterberg H, Fox NC. O3-09-03: Serum Neurofilament Light Levels Correlate With Severity Measures And Neurodegeneration Markers In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2821  0.356
2018 Weston PS, Poole T, Ryan NS, Liang Y, O'Connor A, Heslegrave A, Druyeh R, Mead S, Blennow K, Rossor MN, Schott JM, Zetterberg H, Fox NC. O2-04-04: Longitudinal Measurement Of Serum Neurofilament Light Concentration In Familial Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2660  0.353
2018 Molteni E, Veale T, Altmann A, Cardoso MJ, Benzinger TLS, Jack CR, McDade E, Morris JC, Rossor MN, Ourselin S, Fox NC, Cash DM, Modat M. Ic-P-165: Robust Identification Of Brain Structures Most Discriminative In Detecting Early Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2232  0.395
2018 Keuss SE, Slattery CF, Parker TD, Nicholas JM, Paterson RW, Foulkes AJM, Malone IB, Thomas DL, Modat M, Cash DM, Crutch SJ, Yong K, Ourselin S, Fox NC, Schott JM. P3-437: Longitudinal Cortical Thickness In Sporadic Young Onset Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1800  0.43
2018 O'Connor A, Poole T, Weston PSJ, Ryan NS, Liang Y, Macpherson K, Pavisic IM, Collins J, Druyeh R, Mead S, Blennow K, Rossor MN, Schott JM, Zettenberg H, Fox NC. P3-261: Serum Neurofilament Light Concentration And Progression In Familial Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1621  0.379
2018 Parker TD, Slattery CF, Nicholas JM, Paterson RW, Foulkes AJ, Malone IB, Thomas DL, Modat M, Cash DM, Crutch SJ, Yong K, Ourselin S, Fox NC, Schott JM. P2-390: Differential Hippocampal Subfield Loss In Different Phenotypes Of Young Onset Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1081  0.418
2017 Donegan K, Fox N, Black N, Livingston G, Banerjee S, Burns A. Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. The Lancet. Public Health. 2: e149-e156. PMID 29253388 DOI: 10.1016/S2468-2667(17)30031-2  0.321
2017 Drews A, De S, Flagmeier P, Wirthensohn DC, Chen WH, Whiten DR, Rodrigues M, Vincke C, Muyldermans S, Paterson RW, Slattery CF, Fox NC, Schott JM, Zetterberg H, Dobson CM, et al. Inhibiting the Ca2+ Influx Induced by Human CSF. Cell Reports. 21: 3310-3316. PMID 29241555 DOI: 10.1016/J.Celrep.2017.11.057  0.34
2017 Kehoe PG, Blair PS, Howden B, Thomas DL, Malone IB, Horwood J, Clement C, Selman L, Baber H, Lane A, Coulthard E, Passmore AP, Fox NC, Wilkinson IB, Ben-Shlomo Y. The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial. Journal of Alzheimer's Disease : Jad. PMID 29226862 DOI: 10.3233/Jad-170101  0.436
2017 Rasmussen J, Mahler J, Beschorner N, Kaeser SA, Häsler LM, Baumann F, Nyström S, Portelius E, Blennow K, Lashley T, Fox NC, Sepulveda-Falla D, Glatzel M, Oblak AL, Ghetti B, et al. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 29158413 DOI: 10.1073/Pnas.1713215114  0.406
2017 Weston PSJ, Poole T, Ryan NS, Nair A, Liang Y, Macpherson K, Druyeh R, Malone IB, Ahsan RL, Pemberton H, Klimova J, Mead S, Blennow K, Rossor MN, Schott JM, ... ... Fox NC, et al. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration. Neurology. PMID 29070659 DOI: 10.1212/Wnl.0000000000004667  0.382
2017 Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, et al. The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease. Alzheimer's Research & Therapy. 9: 85. PMID 29070066 DOI: 10.1186/S13195-017-0312-4  0.445
2017 Pavisic IM, Firth NC, Parsons S, Rego DM, Shakespeare TJ, Yong KXX, Slattery CF, Paterson RW, Foulkes AJM, Macpherson K, Carton AM, Alexander DC, Shawe-Taylor J, Fox NC, Schott JM, et al. Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual Functions. Frontiers in Neurology. 8: 377. PMID 28824534 DOI: 10.3389/Fneur.2017.00377  0.405
2017 Szaruga M, Munteanu B, Lismont S, Veugelen S, Horré K, Mercken M, Saido TC, Ryan NS, De Vos T, Savvides SN, Gallardo R, Schymkowitz J, Rousseau F, Fox NC, Hopf C, et al. Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions. Cell. 170: 443-456.e14. PMID 28753424 DOI: 10.1016/J.Cell.2017.07.004  0.375
2017 Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, ... ... Fox NC, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268  0.448
2017 Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, et al. Dementia prevention, intervention, and care. Lancet (London, England). PMID 28735855 DOI: 10.1016/S0140-6736(17)31363-6  0.303
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Fox NC, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.366
2017 Slattery CF, Zhang J, Paterson RW, Foulkes AJM, Carton A, Macpherson K, Mancini L, Thomas DL, Modat M, Toussaint N, Cash DM, Thornton JS, Henley SMD, Crutch SJ, Alexander DC, ... ... Fox NC, et al. ApoE influences regional white-matter axonal density loss in Alzheimer's disease. Neurobiology of Aging. 57: 8-17. PMID 28578156 DOI: 10.1016/J.Neurobiolaging.2017.04.021  0.373
2017 Harper L, Bouwman F, Burton EJ, Barkhof F, Scheltens P, O'Brien JT, Fox NC, Ridgway GR, Schott JM. Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28473626 DOI: 10.1136/Jnnp-2016-314978  0.419
2017 Lane CA, Parker TD, Cash DM, Macpherson K, Donnachie E, Murray-Smith H, Barnes A, Barker S, Beasley DG, Bras J, Brown D, Burgos N, Byford M, Jorge Cardoso M, Carvalho A, ... ... Fox NC, et al. Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development. Bmc Neurology. 17: 75. PMID 28420323 DOI: 10.1186/S12883-017-0846-X  0.448
2017 Lynch DS, Rodrigues Brandão de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, ... ... Fox NC, et al. Clinical and genetic characterization of leukoencephalopathies in adults. Brain : a Journal of Neurology. PMID 28334938 DOI: 10.1093/Brain/Awx045  0.314
2017 Manning EN, Leung KK, Nicholas JM, Malone IB, Cardoso MJ, Schott JM, Fox NC, Barnes J. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset. Neuroinformatics. PMID 28316055 DOI: 10.1007/S12021-017-9326-0  0.382
2017 Sudre CH, Cardoso MJ, Frost C, Barnes J, Barkhof F, Fox N, Ourselin S. APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiology of Aging. 53: 67-75. PMID 28235680 DOI: 10.1016/J.Neurobiolaging.2017.01.014  0.432
2017 Shenkin SD, Pernet C, Nichols TE, Poline JB, Matthews PM, van der Lugt A, Mackay C, Lanyon L, Mazoyer B, Boardman JP, Thompson PM, Fox N, Marcus DS, Sheikh A, et al. Improving data availability for brain image biobanking in healthy subjects: practice-based suggestions from an international multidisciplinary working group. Neuroimage. PMID 28232121 DOI: 10.1016/J.Neuroimage.2017.02.030  0.316
2017 Koriath CA, Bocchetta M, Brotherhood E, Woollacott IO, Norsworthy P, Simón-Sánchez J, Blauwendraat C, Dick KM, Gordon E, Harding SR, Fox NC, Crutch S, Warren JD, Revesz T, Lashley T, et al. The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 75-81. PMID 28229125 DOI: 10.1016/J.Dadm.2016.10.003  0.349
2017 Toombs J, Foiani MS, Paterson RW, Heslegrave A, Wray S, Schott JM, Fox NC, Lunn MP, Blennow K, Zetterberg H. Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration. Journal of Alzheimer's Disease : Jad. PMID 28059797 DOI: 10.3233/Jad-161126  0.316
2017 McElvenny D, Gallo V, Hobbs C, Crutch S, Morris H, Fox N, Zetterberg H, Cross M, Kemp S, Malaspina A, Arden N, Davies M, Pearce N. 0491 Brain health and ageing in retired rugby players, the brain study Occupational and Environmental Medicine. 74. DOI: 10.1136/Oemed-2017-104636.403  0.309
2017 Parker T, Cash DM, Lane CA, Murray-Smith H, Wong A, Malone IB, Burgos N, Modat M, Beasley D, Dickson J, Barnes A, Thomas DL, Cardoso MJ, Klimova J, Ourselin S, ... ... Fox NC, et al. BRAIN VOLUME, CEREBRAL β-AMYLOID DEPOSITION, AND AGEING: A STUDY OF OVER 200 INDIVIDUALS BORN IN THE SAME WEEK IN 1946 Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.534  0.303
2017 Weston PSJ, Poole T, Ryan NS, Nair A, Liang Y, Macpherson K, Druyeh R, Malone IB, Ahsan RL, Pemberton H, Klimova J, Mead S, Blennow K, Rossor MN, Schott JM, ... ... Fox NC, et al. Serum Neurofilament Light Concentration In Familial Alzheimer’S Disease And Association With Markers Of Disease Stage And Severity Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.427  0.329
2017 Fox NC, Ryan NS, Weston PSJ, Chavez-Gutierrez L, Modat M, Cash DM, Ourselin S, Rossor MN. Neuroimaging And Heterogeneity In Familial Alzheimer'S Disease Alzheimers & Dementia. 13: 1211. DOI: 10.1016/J.Jalz.2017.07.377  0.423
2017 McDade E, Wang G, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Hassenstab J, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier KL, Xiong C, Ricardo A, ... ... Fox NC, et al. LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY Alzheimer's & Dementia. 13: P879-P880. DOI: 10.1016/J.Jalz.2017.07.265  0.44
2017 Parsons S, Rego DM, Shawe-Taylor J, Firth NC, Primativo S, Crutch SJ, Shakespeare TJ, Slattery CF, Macpherson K, Carton AM, Schott JM, Alexander DC, Paterson RW, Foulkes AJM, Fox NC, et al. Modelling Eye-Tracking Data To Discriminate Between Alzheimer'S Patients And Healthy Controls Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.237  0.303
2017 Wellington H, Weston PS, Poole T, Paterson RW, Tornqvist U, Portelius E, Fox NC, Blennow K, Zetterberg H, Schott JM. Csf Neurogranin Is Increased In Familial Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.893  0.347
2017 Slattery CF, Zhang J, Paterson RW, Foulkes AJ, Mancini L, Thomas DL, Modat M, Toussaint N, Cash DM, Thornton JS, Alexander DC, Ourselin S, Fox NC, Zhang H, Schott JM. Longitudinal Neurite Orientation Dispersion And Density Imaging In Young-Onset Alzheimer'S Disease Alzheimers & Dementia. 13: 127. DOI: 10.1016/J.Jalz.2017.06.2543  0.406
2017 Young AL, Marinescu RV, Yong K, Firth NC, Oxtoby NP, Cash DM, Fox NC, Crutch SJ, Rohrer JD, Schott JM, Alexander DC. Characterising The Progression Of Alzheimer’S Disease Subtypes Using Subtype And Stage Inference (Sustain) Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2529  0.332
2017 Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Cash DM, Thomas DL, Dick KM, Cardoso MJ, Ourselin S, Swieten JCv, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, ... ... Fox NC, et al. Multiple Distinct Atrophy Patterns Found In Genetic Frontotemporal Dementia Using Subtype And Stage Inference (Sustain) Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2352  0.312
2017 Cash DM, Burgos N, Modat M, Dickson J, Beasley D, Markiewicz P, Lane CA, Parker T, Barnes A, Thomas DL, Cardoso MJ, Malone IB, Veale T, Wallon D, Klimova J, ... ... Fox NC, et al. A comparison of techniques for quantifying amyloid burden on a combined pet/mr scanner Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2276  0.327
2017 Pavisic IM, Primativo S, Firth NC, Shakespeare TJ, Yong K, Slattery CF, Paterson RW, Foulkes AJM, Macpherson K, Carton AM, Alexander DC, Parsons S, Rego DM, Schott JM, Crutch SJ, ... Fox NC, et al. Can Eyetracking Metrics Relate To Performance On Visual Cognitive Tests Of Individuals With Young-Onset Alzheimer’S Disease? Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2158  0.324
2017 Primativo S, Marinescu RV, Firth NC, Yong K, Shakespeare TJ, Gonzalez AS, Carton AM, Lehmann M, Slattery CF, Paterson RW, Foulkes AJM, Ryan NS, Warrington EK, Fox NC, Alexander DC, et al. Longitudinal Evaluation Of Neuropsychological And Neuroimaging Progression In Posterior Cortical Atrophy Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2130  0.307
2017 Macpherson K, Weston PS, Nicholas JM, Donnachie ER, Ariti C, Crutch SJ, Fox NC, Henley SM. Visuomotor Integration In Presymptomatic Familial Alzheimer’S Disease Alzheimers & Dementia. 13: 815. DOI: 10.1016/J.Jalz.2017.06.1115  0.323
2017 Woollacott IO, Bocchetta M, Sudre CH, Ridha BH, Strand C, Courtney R, Ourselin S, Cardoso JM, Warren JD, Rossor MN, Fox NC, Revesz T, Lashley T, Holton J, Rohrer JD. Pathological Correlates Of White Matter Hyperintensities On Cadaveric Mri In Progranulin-Associated Frontotemporal Dementia Alzheimers & Dementia. 13: 805. DOI: 10.1016/J.Jalz.2017.06.1097  0.375
2017 James Lovejoy CE, Arber C, Willumsen N, Ryan NS, Lashley T, Fox NC, Hardy J, Wray S. [P1-220]: 3D CEREBRAL ORGANOIDS AS IN VITRO MODELS FOR ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P327-P327. DOI: 10.1016/J.Jalz.2017.06.040  0.382
2016 Fiford CM, Manning EN, Bartlett JW, Cash DM, Malone IB, Ridgway GR, Lehmann M, Leung KK, Sudre C, Ourselin S, Jan Biessels G, Carmichael OT, Fox NC, Cardoso MJ, Barnes J, et al. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy. Hippocampus. PMID 27933676 DOI: 10.1002/Hipo.22690  0.44
2016 Paterson RW, Heywood WE, Heslegrave AJ, Magdalinou NK, Andreasson U, Sirka E, Bliss E, Slattery CF, Toombs J, Svensson J, Johansson P, Fox NC, Zetterberg H, Mills K, Schott JM. A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology. Translational Psychiatry. 6: e952. PMID 27845782 DOI: 10.1038/Tp.2016.194  0.413
2016 Ryan NS, Nicholas JM, Weston PS, Liang Y, Lashley T, Guerreiro R, Adamson G, Kenny J, Beck J, Chavez-Gutierrez L, de Strooper B, Revesz T, Holton J, Mead S, Rossor MN, ... Fox NC, et al. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series. The Lancet. Neurology. PMID 27777022 DOI: 10.1016/S1474-4422(16)30193-4  0.415
2016 Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0  0.411
2016 Weston PS, Nicholas JM, Lehmann M, Ryan NS, Liang Y, Macpherson K, Modat M, Rossor MN, Schott JM, Ourselin S, Fox NC. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study. Neurology. PMID 27733562 DOI: 10.1212/Wnl.0000000000003322  0.408
2016 Luk C, Jones S, Thomas C, Fox NC, Mok TH, Mead S, Collinge J, Jackson GS. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine. Jama Neurology. PMID 27699415 DOI: 10.1001/Jamaneurol.2016.3733  0.313
2016 Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, ... ... Fox NC, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology. PMID 27581216 DOI: 10.1212/Wnl.0000000000003154  0.342
2016 Weston PS, Paterson RW, Dickson J, Barnes A, Bomanji JB, Kayani I, Lunn MP, Mummery CJ, Warren JD, Rossor MN, Fox NC, Zetterberg H, Schott JM. Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid? Journal of Alzheimer's Disease : Jad. PMID 27567830 DOI: 10.3233/Jad-160302  0.408
2016 Gordon E, Rohrer JD, Fox NC. Advances in neuroimaging in frontotemporal dementia. Journal of Neurochemistry. 138: 193-210. PMID 27502125 DOI: 10.1111/Jnc.13656  0.434
2016 Tai XY, Koepp M, Duncan JS, Fox N, Thompson P, Baxendale S, Liu JY, Reeves C, Michalak Z, Thom M. Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections. Brain : a Journal of Neurology. PMID 27497924 DOI: 10.1093/Brain/Aww187  0.384
2016 Suárez-González A, Lehmann M, Shakespeare TJ, Yong KX, Paterson RW, Slattery CF, Foulkes AJ, Rabinovici GD, Gil-Néciga E, Roldán-Lora F, Schott JM, Fox NC, Crutch SJ. Effect of age at onset on cortical thickness and cognition in posterior cortical atrophy. Neurobiology of Aging. 44: 108-13. PMID 27318138 DOI: 10.1016/J.Neurobiolaging.2016.04.012  0.382
2016 Liang Y, Pertzov Y, Nicholas JM, Henley SM, Crutch S, Woodward F, Leung K, Fox NC, Husain M. Visual short-term memory binding deficit in familial Alzheimer's disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 78: 150-164. PMID 27085491 DOI: 10.1016/J.Cortex.2016.01.015  0.331
2016 Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647  0.469
2016 Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Fox NC, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/Journal.Pone.0152082  0.44
2016 Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, Yong KX, Lehmann M, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Murray ME, Khan QU, Petersen RC, Dickson DW, ... ... Fox NC, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26993346 DOI: 10.1016/J.Jalz.2016.01.010  0.414
2016 Pasquier F, Sadowsky C, Holstein A, Leterme GL, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, Ryan JM. Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967206 DOI: 10.3233/Jad-150376  0.407
2016 Harper L, Fumagalli GG, Barkhof F, Scheltens P, O'Brien JT, Bouwman F, Burton EJ, Rohrer JD, Fox NC, Ridgway GR, Schott JM. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain : a Journal of Neurology. PMID 26936938 DOI: 10.1093/Brain/Aww005  0.389
2016 Andrews KA, Frost C, Modat M, Cardoso MJ, Rowe CC, Villemagne V, Fox NC, Ourselin S, Schott JM. Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis. Neurobiology of Aging. 39: 99-107. PMID 26923406 DOI: 10.1016/J.Neurobiolaging.2015.10.013  0.403
2016 Schott JM, Fox NC. Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know? Brain : a Journal of Neurology. 139: 647-50. PMID 26917584 DOI: 10.1093/Brain/Awv405  0.458
2016 Sander K, Lashley T, Gami P, Gendron T, Lythgoe MF, Rohrer JD, Schott JM, Revesz T, Fox NC, Årstad E. Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26892233 DOI: 10.1016/J.Jalz.2016.01.003  0.39
2016 Wellington H, Paterson RW, Portelius E, Törnqvist U, Magdalinou N, Fox NC, Blennow K, Schott JM, Zetterberg H. Increased CSF neurogranin concentration is specific to Alzheimer disease. Neurology. PMID 26826204 DOI: 10.1212/Wnl.0000000000002423  0.436
2016 Lehmann M, Melbourne A, Dickson JC, Ahmed RM, Modat M, Cardoso MJ, Thomas DL, De Vita E, Crutch SJ, Warren JD, Mahoney CJ, Bomanji J, Hutton BF, Fox NC, Golay X, et al. A novel use of arterial spin labelling MRI to demonstrate focal hypoperfusion in individuals with posterior cortical atrophy: a multimodal imaging study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26733599 DOI: 10.1136/Jnnp-2015-312782  0.336
2016 Koriath C, Adamson G, Druyeh R, Kenny J, Rossor M, Schott J, Collinge J, Fox N, Rohrer J, Mead S. Probing Ftd Genetics With Next-Generation Sequencing Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-315106.61  0.319
2016 Weston P, Liang Y, Henley S, Nicholas J, Ryan N, Schott J, Rossor M, Butler C, Zeman A, Fox N. Long-Term Forgetting In Preclinical Familial Alzheimer'S Disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-315106.18  0.362
2016 Wellington H, Paterson RW, Törnqvist U, Portelius E, Fox NC, Blennow K, Zetterberg H, Schott JM. Neurogranin: A Specific Synaptic Biomarker For Amnestic Alzheimer’S Disease? Alzheimers & Dementia. 12: 483. DOI: 10.1016/J.Jalz.2016.06.952  0.311
2016 Mutsaerts HJMM, Rohrer JD, Thomas DL, Cash DM, Vita Ed, Nicholas JM, Swieten JCv, Dopper EGP, Jiskoot LC, Minkelen Rv, Rombouts SARB, Dick KM, Bocchetta M, Cardoso MJ, Espak M, ... ... Fox NC, et al. Cerebral Perfusion As An Imaging Biomarker Of Presymptomatic Genetic Frontotemporal Dementia: Preliminary Results From The Genetic Frontotemporal Dementia Initiative (Genfi) Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.772  0.417
2016 Marinescu RV, Young AL, Oxtoby NP, Firth NC, Lorenzi M, Eshaghi A, Wottschel V, Cardoso MJ, Modat M, Yong K, Primativo S, Fox NC, Lehmann M, Shakespeare TJ, Crutch SJ, et al. A Data-Driven Comparison Of The Progression Of Brain Atrophy In Posterior Cortical Atrophy And Alzheimer'S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.756  0.445
2016 McDade E, Weng H, Wang G, Xiong C, Fagan AM, Hassenstab J, Marcus DS, Morris JC, Benzinger TL, Cairns NJ, Goate AM, Buckles V, Holtzman DM, Berman S, Ghetti B, ... ... Fox NC, et al. O5-02-01: Longitudinal Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease: The Dominantly Inherited Alzheimer Network Alzheimer's & Dementia. 12: P378-P379. DOI: 10.1016/J.Jalz.2016.06.710  0.415
2016 Cash DM, Kinnunen KM, Weston PS, Ryan NS, Modat M, Bateman R, Morris JC, Ourselin S, Rossor MN, Benzinger TLS, Fox NC. Longitudinal Atrophy In Autosomal Dominant Ad And Sporadic Ad: Lessons From Dian Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.688  0.355
2016 Lee S, Zimmerman ME, Viqar F, Narkhede A, Tosto G, Lee Smith Benzinger T, Marcus DS, Goate AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, et al. O2-03-02: are White Matter Hyperintensities a Core Feature of Alzheimer’s Disease or Just a Reflection of Amyloid Angiopathy? Evidence From the Dominantly Inherited Alzheimer Network (DIAN) Alzheimer's & Dementia. 12: P226-P226. DOI: 10.1016/J.Jalz.2016.06.406  0.37
2016 Paterson RW, Slattery CF, Magdalinou NK, Toombs J, Chapman MD, Lunn M, Blennow K, Fox NC, Zetterberg H, Schott JM. Csf In The Differential Diagnosis Of Alzheimer'S Disease: Clinical Utility Of An Extended Panel Of Biomarkers In A Specialist Cognitive Clinic Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.356  0.403
2016 Scheltens P, Blennow K, Rowe CC, Fox NC, Lovestone S, DeCarli C, Snyder HM, Amouyel P, Carrillo MC. FTS3-01-03: Biomarkers for Vascular Contributions to Dementia Alzheimer's & Dementia. 12: P276-P277. DOI: 10.1016/J.Jalz.2016.06.2386  0.314
2016 Foulkes AJM, Slattery CF, Paterson RW, Modat M, Callaghan MF, Weiskopf N, Schott JM, Fox NC. Phenotypic Differences In Quantitative Mri Parameters In Typical Amnestic Alzheimer’S Disease And Pca In A Young-Onset Alzheimer’S Cohort Alzheimers & Dementia. 12: 119. DOI: 10.1016/J.Jalz.2016.06.192  0.378
2016 Cash DM, Ridgway GR, Kinnunen KM, Benzinger TLS, Wallon D, Jack CR, Bateman R, Morris JC, Rossor MN, Ourselin S, Fox NC. A Longitudinal Morphometric Study Of Familial Alzheimer’S Disease: Results From Dian Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.172  0.432
2016 Oxtoby NP, Young AL, Lorenzi M, Cash DM, Weston PSJ, Ourselin S, Fox NC, Schott JM, Alexander DC. Model-Based Comparison Of Autosomal-Dominant And Late-Onset Alzheimer'S Disease Progression In The Dian And Adni Studies Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1514  0.444
2015 Paterson RW, Toombs J, Chapman MD, Nicholas JM, Heslegrave AJ, Slattery CF, Foulkes AJ, Clark CN, Lane CA, Weston PS, Lunn MP, Fox NC, Zetterberg H, Schott JM. Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice? Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 380-4. PMID 27239518 DOI: 10.1016/J.Dadm.2015.06.003  0.374
2015 Weston PS, Paterson RW, Modat M, Burgos N, Cardoso MJ, Magdalinou N, Lehmann M, Dickson JC, Barnes A, Bomanji JB, Kayani I, Cash DM, Ourselin S, Toombs J, Lunn MP, ... ... Fox NC, et al. Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 440-446. PMID 26835507 DOI: 10.1016/J.Dadm.2015.10.001  0.318
2015 Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. "Why therapy development for dementia has failed in the last two decades?" Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26710325 DOI: 10.1016/J.Jalz.2015.12.003  0.318
2015 Wray S, Fox NC. Stem cell therapy for Alzheimer's disease: hope or hype? The Lancet. Neurology. PMID 26704440 DOI: 10.1016/S1474-4422(15)00382-8  0.337
2015 Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, Carecchio M, Reid E, Heslegrave A, Fenoglio C, Scarpini E, Schott JM, Fox NC, Hardy J, Bahtia K, et al. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Molecular Neurodegeneration. 10: 64. PMID 26627638 DOI: 10.1186/S13024-015-0059-Y  0.44
2015 Ryan NS, Rossor MN, Fox NC. Alzheimer's disease in the 100 years since Alzheimer's death. Brain : a Journal of Neurology. 138: 3816-21. PMID 26541346 DOI: 10.1093/Brain/Awv316  0.436
2015 Szaruga M, Veugelen S, Benurwar M, Lismont S, Sepulveda-Falla D, Lleo A, Ryan NS, Lashley T, Fox NC, Murayama S, Gijsen H, De Strooper B, Chávez-Gutiérrez L. Qualitative changes in human γ-secretase underlie familial Alzheimer's disease. The Journal of Experimental Medicine. PMID 26481686 DOI: 10.1084/Jem.20150892  0.425
2015 Manning EN, Macdonald KE, Leung KK, Young J, Pepple T, Lehmann M, Zuluaga MA, Cardoso MJ, Schott JM, Ourselin S, Crutch S, Fox NC, Barnes J. Differential hippocampal shapes in posterior cortical atrophy patients: A comparison with control and typical AD subjects. Human Brain Mapping. PMID 26461053 DOI: 10.1002/Hbm.22999  0.412
2015 Paterson RW, Toombs J, Slattery CF, Nicholas JM, Andreasson U, Magdalinou NK, Blennow K, Warren JD, Mummery CJ, Rossor MN, Lunn MP, Crutch SJ, Fox NC, Zetterberg H, Schott JM. Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis. Journal of Neurology. PMID 26410752 DOI: 10.1007/S00415-015-7904-3  0.422
2015 Ryan NS, Biessels GJ, Kim L, Nicholas JM, Barber PA, Walsh P, Gami P, Morris HR, Bastos-Leite AJ, Schott JM, Beck J, Mead S, Chavez-Gutierrez L, de Strooper B, Rossor MN, ... ... Fox NC, et al. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease. Neurobiology of Aging. PMID 26410308 DOI: 10.1016/J.Neurobiolaging.2015.08.026  0.392
2015 Slattery CF, Malone IB, Clegg SL, Warren JD, Fox NC. Reversible frontotemporal brain sagging syndrome. Neurology. 85: 833. PMID 26324864 DOI: 10.1212/Wnl.0000000000001898  0.312
2015 Cash DM, Frost C, Iheme LO, Ünay D, Kandemir M, Fripp J, Salvado O, Bourgeat P, Reuter M, Fischl B, Lorenzi M, Frisoni GB, Pennec X, Pierson RK, Gunter JL, ... ... Fox NC, et al. Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge. Neuroimage. 123: 149-164. PMID 26275383 DOI: 10.1016/J.Neuroimage.2015.07.087  0.387
2015 Downey LE, Mahoney CJ, Buckley AH, Golden HL, Henley SM, Schmitz N, Schott JM, Simpson IJ, Ourselin S, Fox NC, Crutch SJ, Warren JD. White matter tract signatures of impaired social cognition in frontotemporal lobar degeneration. Neuroimage. Clinical. 8: 640-51. PMID 26236629 DOI: 10.1016/J.Nicl.2015.06.005  0.315
2015 Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, et al. Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials. Neurology. PMID 26208959 DOI: 10.1212/Wnl.0000000000001877  0.308
2015 Walton J, Ryan N, Crutch S, Rohrer JD, Fox N. The importance of dementia support groups. Bmj (Clinical Research Ed.). 351: h3875. PMID 26206171 DOI: 10.1136/Bmj.H3875  0.368
2015 Jack CR, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, et al. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 740-56. PMID 26194310 DOI: 10.1016/J.Jalz.2015.05.002  0.438
2015 Weston PS, Simpson IJ, Ryan NS, Ourselin S, Fox NC. Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration. Alzheimer's Research & Therapy. 7: 47. PMID 26136857 DOI: 10.1186/S13195-015-0132-3  0.457
2015 Sposito T, Preza E, Mahoney CJ, Setó-Salvia N, Ryan NS, Morris HR, Arber C, Devine MJ, Houlden H, Warner TT, Bushell TJ, Zagnoni M, Kunath T, Livesey FJ, Fox NC, et al. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT. Human Molecular Genetics. PMID 26136155 DOI: 10.1093/Hmg/Ddv246  0.333
2015 Lynch DS, Jaunmuktane Z, Sheerin UM, Phadke R, Brandner S, Milonas I, Dean A, Bajaj N, McNicholas N, Costello D, Cronin S, McGuigan C, Rossor M, Fox N, Murphy E, et al. Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25935893 DOI: 10.1136/Jnnp-2015-310788  0.3
2015 Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25872513 DOI: 10.1136/Jnnp-2014-310090  0.364
2015 Vemuri P, Senjem ML, Gunter JL, Lundt ES, Tosakulwong N, Weigand SD, Borowski BJ, Bernstein MA, Zuk SM, Lowe VJ, Knopman DS, Petersen RC, Fox NC, Thompson PM, Weiner MW, et al. Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease. Neuroimage. 113: 61-9. PMID 25797830 DOI: 10.1016/J.Neuroimage.2015.03.026  0.467
2015 Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, ... ... Fox NC, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Molecular Psychiatry. PMID 25778476 DOI: 10.1038/Mp.2015.23  0.34
2015 Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, ... ... Fox NC, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. The Lancet. Neurology. 14: 253-62. PMID 25662776 DOI: 10.1016/S1474-4422(14)70324-2  0.389
2015 Portelius E, Lashley T, Westerlund A, Persson R, Fox NC, Blennow K, Revesz T, Zetterberg H. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Neuro-Degenerative Diseases. 15: 50-7. PMID 25591542 DOI: 10.1159/000369465  0.402
2015 Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25589779 DOI: 10.1136/Jnnp-2014-309562  0.379
2015 Leung KK, Malone IM, Ourselin S, Gunter JL, Bernstein MA, Thompson PM, Jack CR, Weiner MW, Fox NC. Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement. Neuroimage. 107: 46-53. PMID 25481794 DOI: 10.1016/J.Neuroimage.2014.11.049  0.332
2015 Ryan NS, Lashley T, Revesz T, Dantu K, Fox NC, Morris HR. Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 1069-74. PMID 25408217 DOI: 10.3233/Jad-142325  0.429
2015 Mahoney CJ, Simpson IJ, Nicholas JM, Fletcher PD, Downey LE, Golden HL, Clark CN, Schmitz N, Rohrer JD, Schott JM, Zhang H, Ourselin S, Warren JD, Fox NC. Longitudinal diffusion tensor imaging in frontotemporal dementia. Annals of Neurology. 77: 33-46. PMID 25363208 DOI: 10.1002/Ana.24296  0.375
2015 Prados F, Cardoso MJ, Leung KK, Cash DM, Modat M, Fox NC, Wheeler-Kingshott CA, Ourselin S. Measuring brain atrophy with a generalized formulation of the boundary shift integral. Neurobiology of Aging. 36: S81-90. PMID 25264346 DOI: 10.1016/J.Neurobiolaging.2014.04.035  0.411
2015 Malone IB, Leung KK, Clegg S, Barnes J, Whitwell JL, Ashburner J, Fox NC, Ridgway GR. Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance. Neuroimage. 104: 366-72. PMID 25255942 DOI: 10.1016/J.Neuroimage.2014.09.034  0.358
2015 Weston P, Paterson R, Lehmann M, Modat M, Bomanji J, Kayani I, Dickson J, Barnes A, Cash D, Ourselin S, Zetterberg H, Toombs J, Warren J, Rossor M, Fox N, et al. Using Florbetapir Pet To Increase Diagnostic Certainty In Atypical Dementias Journal of Neurology, Neurosurgery, and Psychiatry. 86. DOI: 10.1136/Jnnp-2015-312379.24  0.405
2015 Paterson RW, Toombs J, Slattery CF, Nicholas J, Blennow K, Andreasson U, Magdalinou NK, Warren JD, Mummery CJ, Rossor MN, Lunn M, Crutch SJ, Fox NC, Zetterberg H, Schott JM. Dissecting IWG-2 typical and atypical Alzheimer's disease: Insights from cerebrospinal fluid analysis Alzheimers & Dementia. 11: 254. DOI: 10.1016/J.Jalz.2015.07.315  0.411
2015 Agustus JL, Clark CN, Golden HL, Slattery CF, Fletcher PD, Cohen MH, Downey LE, Mummery CJ, Rossor MN, Schott JM, Mead S, Rohrer JD, Fox NC, Warren JD. Dementia and music: fMRI signatures of molecular nexopathies Alzheimers & Dementia. 11: 528. DOI: 10.1016/J.Jalz.2015.06.658  0.323
2015 Ryan NS, Walsh P, Gami P, Troakes C, Rossor MN, Fox NC, Revesz T, Lashley T. Genetic influences on amyloid angiopathy and white matter pathology in familial Alzheimer's disease: A comparison of app and PSEN1 mutations Alzheimers & Dementia. 11: 431. DOI: 10.1016/J.Jalz.2015.06.411  0.417
2015 Wellington H, Törnqvist U, Portelius E, Paterson RW, Magdalinou NK, Fox NC, Blennow K, Schott JM, Zetterberg H. Quantification of the synaptic protein neurogranin in cerebrospinal fluid across different neurodegenerative diseases: A selective Alzheimer’s disease biomarker? Alzheimers & Dementia. 11: 340. DOI: 10.1016/J.Jalz.2015.06.206  0.34
2015 Slattery CF, Zhang J, Paterson RW, Foulkes AJM, Mancini L, Thomas DL, Modat M, Toussaint N, Cash DM, Thornton JS, Alexander DC, Ourselin S, Fox NC, Zhang H, Schott JM. Neurite orientation dispersion and density imaging (NODDI) in young onset Alzheimer's disease and its syndromic variants Alzheimers & Dementia. 11: 91. DOI: 10.1016/J.Jalz.2015.06.156  0.391
2015 Weston PSJ, Lehmann M, Nicholas JM, Harper L, Ryan NS, MacPherson K, Woodward F, Schott JM, Rossor MN, Fox NC. A cortical signature of familial Alzheimer’s disease: Cross-sectional and longitudinal study of presymptomatic changes Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.139  0.313
2015 Harper L, Burton EJ, Bouwman F, O'Brien JT, Barkhof F, Scheltens P, Fox NC, Ridgway GR, Schott JM. Distinct patterns of atrophy in postmortem confirmed dementias Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.114  0.336
2014 Cash DM, Rohrer JD, Ryan NS, Ourselin S, Fox NC. Imaging endpoints for clinical trials in Alzheimer's disease. Alzheimer's Research & Therapy. 6: 87. PMID 25621018 DOI: 10.1186/S13195-014-0087-9  0.394
2014 Prins ND, van der Flier WA, Knol DL, Fox NC, Brashear HR, Nye JS, Barkhof F, Scheltens P. The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial. Alzheimer's Research & Therapy. 6: 47. PMID 25478019 DOI: 10.1186/Alzrt275  0.377
2014 Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O'Brien JT, Fox NC, Halliday GM, Schott JM. Biomarkers in dementia: clinical utility and new directions. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1426-34. PMID 25261571 DOI: 10.1136/Jnnp-2014-307662  0.354
2014 Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney CJ, Rohrer JD, Kenny J, Lowe J, Leung KK, Barnes J, Clegg SL, ... ... Fox NC, et al. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 602-608.e4. PMID 25160042 DOI: 10.1016/J.Jalz.2014.05.1751  0.439
2014 Ryan NS, Shakespeare TJ, Lehmann M, Keihaninejad S, Nicholas JM, Leung KK, Fox NC, Crutch SJ. Motor features in posterior cortical atrophy and their imaging correlates. Neurobiology of Aging. 35: 2845-57. PMID 25086839 DOI: 10.1016/J.Neurobiolaging.2014.05.028  0.305
2014 Paterson RW, Bartlett JW, Blennow K, Fox NC, Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM. Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals. Translational Psychiatry. 4: e419. PMID 25072324 DOI: 10.1038/Tp.2014.58  0.436
2014 Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Fox NC, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654  0.429
2014 Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, Schott JM, Alexander DC. A data-driven model of biomarker changes in sporadic Alzheimer's disease. Brain : a Journal of Neurology. 137: 2564-77. PMID 25012224 DOI: 10.1016/J.Jalz.2014.04.180  0.448
2014 Hill DL, Schwarz AJ, Isaac M, Pani L, Vamvakas S, Hemmings R, Carrillo MC, Yu P, Sun J, Beckett L, Boccardi M, Brewer J, Brumfield M, Cantillon M, Cole PE, ... Fox N, et al. Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 421-9.e3. PMID 24985687 DOI: 10.1016/J.Jalz.2013.07.003  0.383
2014 Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, ... ... Fox NC, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. The Lancet. Neurology. 13: 686-99. PMID 24943344 DOI: 10.1016/S1474-4422(14)70065-1  0.323
2014 Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596  0.335
2014 Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, ... ... Fox NC, et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. Plos One. 9: e94661. PMID 24922517 DOI: 10.1371/Journal.Pone.0094661  0.383
2014 Manning EN, Barnes J, Cash DM, Bartlett JW, Leung KK, Ourselin S, Fox NC. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD. Plos One. 9: e97608. PMID 24878738 DOI: 10.1371/Journal.Pone.0097608  0.418
2014 Barnes J, Fox NC. The search for early markers of AD: hippocampal atrophy and memory deficits. International Psychogeriatrics / Ipa. 26: 1065-6. PMID 24874029 DOI: 10.1017/S1041610214000623  0.421
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.455
2014 Mahoney CJ, Ridgway GR, Malone IB, Downey LE, Beck J, Kinnunen KM, Schmitz N, Golden HL, Rohrer JD, Schott JM, Rossor MN, Ourselin S, Mead S, Fox NC, Warren JD. Profiles of white matter tract pathology in frontotemporal dementia. Human Brain Mapping. 35: 4163-79. PMID 24510641 DOI: 10.1002/Hbm.22468  0.412
2014 Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. The New England Journal of Medicine. 370: 322-33. PMID 24450891 DOI: 10.1056/Nejmoa1304839  0.424
2014 Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, ... ... Fox N, et al. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica. 127: 407-18. PMID 24442578 DOI: 10.1007/S00401-013-1239-X  0.324
2014 Yu P, Sun J, Wolz R, Stephenson D, Brewer J, Fox NC, Cole PE, Jack CR, Hill DL, Schwarz AJ. Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size. Neurobiology of Aging. 35: 808-18. PMID 24211008 DOI: 10.1016/J.Neurobiolaging.2013.09.039  0.36
2014 Harper L, Barkhof F, Scheltens P, Schott JM, Fox NC. An algorithmic approach to structural imaging in dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 692-8. PMID 24133287 DOI: 10.1136/Jnnp-2013-306285  0.371
2014 Beck J, Pittman A, Adamson G, Campbell T, Kenny J, Houlden H, Rohrer JD, de Silva R, Shoai M, Uphill J, Poulter M, Hardy J, Mummery CJ, Warren JD, Schott JM, ... Fox NC, et al. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiology of Aging. 35: 261-5. PMID 23998997 DOI: 10.1016/J.Neurobiolaging.2013.07.017  0.301
2014 Liang Y, Gordon E, Rohrer J, Downey L, de Silva R, Jäger HR, Nicholas J, Modat M, Cardoso MJ, Mahoney C, Warren J, Rossor M, Fox N, Caine D. A cognitive chameleon: lessons from a novel MAPT mutation case. Neurocase. 20: 684-94. PMID 23998300 DOI: 10.1080/13554794.2013.826697  0.367
2014 Merwick Á, Ahmed R, Murphy E, Davagnanam I, Schott J, Mummery C, Lachmann R, Houlden H, Fox N. Adult Leukodystrophy: Multi-Disciplinary Structured Approach Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309236.81  0.335
2014 Fox N. Presymptomatic Treatment For The Dementias: Plausability And Perils Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-308883.6  0.445
2014 Weston PSJ, Cash DM, Ryan NS, Leung KK, Fox N. Brain Atrophy In Mci And Presymptomatic Neurodegeneration: Insights From, And Advantages Of, Longitudinal Studies Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.055  0.339
2014 Shakespeare T, Simpson I, Malone I, Ryan NS, Crutch S, Ourselin S, Fox N. Different Patterns Of Structural Connectivity In Early-Onset Sporadic Ad: A Longitudinal Dti Study Of White Matter Structure In Pca And Typical Ad Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.875  0.347
2014 Weston PSJ, Lehmann M, Ryan NS, Liang Y, Woodward FJ, Macpherson K, Rossor M, Fox N. A Cortical Atrophy Signature Of Familial Alzheimer'S Disease: Temporal Evolution Of Presymptomatic Changes Alzheimers & Dementia. 10: 401. DOI: 10.1016/J.Jalz.2014.05.496  0.335
2014 Cover KS, van Schijndel R, Versteeg A, Leung KK, Mulder ER, de Jong RA, Visser PJ, Grenier B, Revillard J, Manset D, Redolfi A, van Dijk BW, Vrenken H, Fox NC, Frisoni GB, et al. P1-235: THE HIPPOCAMPAL BOUNDARY SHIFT INTEGRAL IS 70% MORE REPRODUCIBLE THAN OTHER ATROPHY ALGORITHMS Alzheimer's & Dementia. 10: P390-P391. DOI: 10.1016/J.Jalz.2014.05.474  0.339
2014 Kinnunen KM, Leung KK, Finnegan S, Leite AJB, Lehmann M, Nicholas JM, Cash DM, Ryan NS, Rossor MN, Ourselin S, Fox NC. Automated Segmentation Of Thalamus From Mri: Method Validation And Comparison For Volumetric Measurement In Familial Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.200  0.409
2014 Ryan NS, Simpson I, Nicholas JM, Leung KK, Clegg S, Macpherson K, Kinnunen KM, Weston PSJ, Cash DM, Malone IB, Zhang H, Daga P, Toussaint N, Rossor MN, Ourselin S, ... Fox NC, et al. Longitudinal Volumetric And Diffusion Tensor Imaging In Familial Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.182  0.39
2014 Modat M, Simpson IJ, Cash DM, Cardoso J, Weston PSJ, Ryan NS, Fox NC, Ourselin S. Multi-Modal Image Registration: Application To Familial Ad Subjects Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1649  0.331
2014 Cash DM, Kinnunen KM, Leung KK, Ahsan L, Cardoso J, Modat M, Nicholas J, Malone I, Benzinger T, Jack CR, Thompson P, Saykin AJ, Sperling RR, Villemagne V, Weiner M, ... ... Fox N, et al. Longitudinal Rates Of Atrophy In Familial Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.112  0.419
2014 Harper L, Burton E, Bouwman FH, Rozemuller A, Barkhof F, Scheltens P, O'Brien J, Fox N, Ridgway GR, Schott JM. Classification Of Pathology Using Brain Substructure Volumes In Post Mortem Confirmed Dementias Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.062  0.381
2014 Manning EN, Macdonald KE, Leung KK, Young J, Pepple T, Ourselin S, Lehmann M, Crutch S, Fox NC, Barnes J. Differential Hippocampal Shapes In Posterior Cortical Atrophy Patients: A Comparison With Control And Typical Ad Subjects Alzheimers & Dementia. 10: 287. DOI: 10.1016/J.Jalz.2014.04.477  0.351
2013 Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Fox NC, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110  0.417
2013 Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, ... ... Fox NC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics. 45: 1452-8. PMID 24162737 DOI: 10.1038/Ng.2802  0.389
2013 Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, ... ... Fox NC, et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 81: 1425-33. PMID 24049139 DOI: 10.1212/Wnl.0B013E3182A841C6  0.452
2013 Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, ... ... Fox N, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Revue Neurologique. 169: 737-43. PMID 24016464 DOI: 10.1016/J.Neurol.2013.07.017  0.36
2013 Rohrer JD, Warren JD, Fox NC, Rossor MN. Presymptomatic studies in genetic frontotemporal dementia. Revue Neurologique. 169: 820-4. PMID 24012408 DOI: 10.1016/J.Neurol.2013.07.010  0.403
2013 Toombs J, Paterson RW, Lunn MP, Nicholas JM, Fox NC, Chapman MD, Schott JM, Zetterberg H. Identification of an important potential confound in CSF AD studies: aliquot volume. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 51: 2311-7. PMID 23940064 DOI: 10.1515/Cclm-2013-0293  0.398
2013 Rohrer JD, Beck J, Plagnol V, Gordon E, Lashley T, Revesz T, Janssen JC, Fox NC, Warren JD, Rossor MN, Mead S, Schott JM. Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1411-2. PMID 23904625 DOI: 10.1136/Jnnp-2013-306116  0.378
2013 Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8  0.379
2013 Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, Marcus DS, Thompson P, Saykin AJ, Correia S, Schofield PR, ... ... Fox NC, et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology. 81: 736-44. PMID 23884042 DOI: 10.1212/Wnl.0B013E3182A1Aafe  0.417
2013 Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, ... ... Fox NC, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. Neurology. 12: 822-38. PMID 23867200 DOI: 10.1016/S1474-4422(13)70124-8  0.385
2013 Ryan NS, Fox NC. Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer's disease. Brain : a Journal of Neurology. 136: e259. PMID 23824491 DOI: 10.1093/Brain/Awt168  0.389
2013 Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, ... ... Fox N, et al. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 438-44. PMID 23809364 DOI: 10.1016/J.Jalz.2013.03.007  0.356
2013 Guerreiro R, Kara E, Le Ber I, Bras J, Rohrer JD, Taipa R, Lashley T, Dupuits C, Gurunlian N, Mochel F, Warren JD, Hannequin D, Sedel F, Depienne C, Camuzat A, ... ... Fox NC, et al. Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. Jama Neurology. 70: 875-82. PMID 23649896 DOI: 10.1001/Jamaneurol.2013.698  0.315
2013 Massey LA, Jäger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton J, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Micallef C. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology. 80: 1856-61. PMID 23616165 DOI: 10.1212/Wnl.0B013E318292A2D2  0.374
2013 Andrews KA, Modat M, Macdonald KE, Yeatman T, Cardoso MJ, Leung KK, Barnes J, Villemagne VL, Rowe CC, Fox NC, Ourselin S, Schott JM. Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials. Plos One. 8: e58816. PMID 23554933 DOI: 10.1371/Journal.Pone.0058816  0.37
2013 Ryan NS, Keihaninejad S, Shakespeare TJ, Lehmann M, Crutch SJ, Malone IB, Thornton JS, Mancini L, Hyare H, Yousry T, Ridgway GR, Zhang H, Modat M, Alexander DC, Rossor MN, ... ... Fox NC, et al. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain : a Journal of Neurology. 136: 1399-414. PMID 23539189 DOI: 10.1093/Brain/Awt065  0.366
2013 Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Neurobiology of Aging. 34: 1996-2002. PMID 23522844 DOI: 10.1016/J.Neurobiolaging.2013.02.003  0.478
2013 Jorge Cardoso M, Leung K, Modat M, Keihaninejad S, Cash D, Barnes J, Fox NC, Ourselin S. STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Medical Image Analysis. 17: 671-84. PMID 23510558 DOI: 10.1016/J.Media.2013.02.006  0.31
2013 Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, ... ... Fox NC, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. American Journal of Human Genetics. 92: 345-53. PMID 23434116 DOI: 10.1016/J.Ajhg.2013.01.011  0.385
2013 Rohrer JD, Caso F, Mahoney C, Henry M, Rosen HJ, Rabinovici G, Rossor MN, Miller B, Warren JD, Fox NC, Ridgway GR, Gorno-Tempini ML. Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia. Brain and Language. 127: 121-6. PMID 23395096 DOI: 10.1016/J.Bandl.2012.12.008  0.401
2013 Scahill RI, Ridgway GR, Bartlett JW, Barnes J, Ryan NS, Mead S, Beck J, Clarkson MJ, Crutch SJ, Schott JM, Ourselin S, Warren JD, Hardy J, Rossor MN, Fox NC. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations. Journal of Alzheimer's Disease : Jad. 35: 199-212. PMID 23380992 DOI: 10.3233/Jad-121255  0.456
2013 Keihaninejad S, Zhang H, Ryan NS, Malone IB, Modat M, Cardoso MJ, Cash DM, Fox NC, Ourselin S. An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease. Neuroimage. 72: 153-63. PMID 23370057 DOI: 10.1016/J.Neuroimage.2013.01.044  0.386
2013 Mahoney CJ, Malone IB, Ridgway GR, Buckley AH, Downey LE, Golden HL, Ryan NS, Ourselin S, Schott JM, Rossor MN, Fox NC, Warren JD. White matter tract signatures of the progressive aphasias. Neurobiology of Aging. 34: 1687-99. PMID 23312804 DOI: 10.1016/J.Neurobiolaging.2012.12.002  0.369
2013 Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology. 80: 648-54. PMID 23303849 DOI: 10.1212/Wnl.0B013E318281Ccd3  0.444
2013 Malone IB, Cash D, Ridgway GR, MacManus DG, Ourselin S, Fox NC, Schott JM. MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset. Neuroimage. 70: 33-6. PMID 23274184 DOI: 10.1016/J.Neuroimage.2012.12.044  0.402
2013 Crutch SJ, Schott JM, Rabinovici GD, Boeve BF, Cappa SF, Dickerson BC, Dubois B, Graff-Radford NR, Krolak-Salmon P, Lehmann M, Mendez MF, Pijnenburg Y, Ryan NS, Scheltens P, Shakespeare T, ... ... Fox NC, et al. Shining a light on posterior cortical atrophy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 463-5. PMID 23274153 DOI: 10.1016/J.Jalz.2012.11.004  0.361
2013 Barnes J, Bartlett JW, Fox NC, Schott JM. Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials. Journal of Alzheimer's Disease : Jad. 34: 431-7. PMID 23229078 DOI: 10.3233/Jad-121936  0.374
2013 Wyman BT, Harvey DJ, Crawford K, Bernstein MA, Carmichael O, Cole PE, Crane PK, DeCarli C, Fox NC, Gunter JL, Hill D, Killiany RJ, Pachai C, Schwarz AJ, Schuff N, et al. Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 332-7. PMID 23110865 DOI: 10.1016/J.Jalz.2012.06.004  0.314
2013 Liang Y, Ryan NS, Schott JM, Fox NC. Imaging the onset and progression of Alzheimer's disease: implications for prevention trials. Journal of Alzheimer's Disease : Jad. 33: S305-12. PMID 22647263 DOI: 10.3233/Jad-2012-129010  0.449
2013 Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC. Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiology of Aging. 34: 73-82. PMID 22516280 DOI: 10.1016/J.Neurobiolaging.2012.03.010  0.418
2013 Mahoney C, Yeatman T, Rohrer J, Manning E, Leung K, Rossor M, Warren J, Fox N. The Evolution Of Frontotemporal Dementia Due To The Mapt Mutation: A Seventeen Year Natural History Study Journal of Neurology, Neurosurgery, and Psychiatry. 84. DOI: 10.1136/Jnnp-2013-306573.86  0.426
2013 Rossor M, Ahmed R, Liang Y, Douglas J, Mahoney C, Warren J, Schott J, Fox N. Longitudinal Research Into Alzheimer'S Disease, Fronto–Temporal Dementia And Other Dementias Journal of Neurology, Neurosurgery, and Psychiatry. 84. DOI: 10.1136/Jnnp-2013-306573.68  0.451
2013 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Fox N, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 45: 712-712. DOI: 10.1038/Ng0613-712A  0.351
2013 Mills S, Mallmann J, Santacruz A, Fuqua A, Carril M, Aisen P, Althage M, Belyew S, Benzinger T, Brooks W, Buckles V, Cairns N, Clifford D, Danek A, Fagan A, ... ... Fox N, et al. Erratum to “Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial” [Rev. Neurol. 169 (10) (2013) 737–743] Revue Neurologique. 169: 1018. DOI: 10.1016/J.Neurol.2013.10.005  0.314
2013 Novak G, Einstein S, Lu Y, Tudor IC, Gregg K, Collins P, Wyman B, Yuen E, Nielsen C, Grundman M, Brashear RH, Fox N, Liu E. Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab Alzheimers & Dementia. 9: 289. DOI: 10.1016/J.Jalz.2013.05.583  0.426
2013 Novak G, Einstein S, Tudor IC, Gregg K, Collins P, Wyman B, Yuen E, Nielsen C, Grundman M, Brashear RH, Fox N, Liu E. The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab Alzheimers & Dementia. 9: 287. DOI: 10.1016/J.Jalz.2013.05.579  0.424
2013 Einstein S, Bouix S, Nielsen C, Clegg S, Les A, Simon H, Hill D, Margolin R, Sperling R, Fox N, Liu E, Novak G. The impact of gradient field distortion on the calculation of brain atrophy in Alzheimer's disease, derived from volumetric MRI using the boundary shift integral Alzheimers & Dementia. 9: 105. DOI: 10.1016/J.Jalz.2013.05.561  0.386
2013 Paterson R, Toombs J, Fox N, Nicholas J, Miles C, Schott J, Zetterberg H. Identification of an important potential confound in CSF Alzheimer's disease studies: Aliquot volume Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.406  0.444
2013 Andreasson U, Lautner R, Schott J, Mattsson N, Hansson O, Herukka S, Ewers M, Hampel H, Wallin A, Minthon L, Fox N, Hardy J, Blennow K, Zetterberg H. CSF biomarkers for Alzheimer's pathology and the effect size of APOE-ε4 Alzheimers & Dementia. 9: 174. DOI: 10.1016/J.Jalz.2013.05.282  0.386
2013 Leung K, Woodward F, Thompson P, Fox N. Effects of changing from non-accelerated to accelerated MRI in brain atrophy measurement Alzheimers & Dementia. 9: 90. DOI: 10.1016/J.Jalz.2013.05.1184  0.312
2013 Leung K, Nielsen C, Clegg S, Malone I, Nicholas J, Cash D, Ourselin S, Thompson P, Jack C, Weiner M, Fox N. Comparison of accelerated and nonaccelerated MRI in ADNI: Effects on measures of brain and ventricular volumes and rates of atrophy Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1165  0.317
2013 Blazey T, Jack C, Kantarci K, Preboske G, Ringman J, Brickman A, Raichle M, Hornbeck R, Saykin A, Salloway S, McDade E, Rossor M, Fox N, Thompson P, Correia S, et al. Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.100  0.402
2013 Mahoney C, Zhang H, Malone I, Nicholas J, Schmitz N, Schott J, Warren J, Fox N. Tracking white matter degeneration in frontotemporal dementia using serial diffusion tensor imaging Alzheimers & Dementia. 9: 269. DOI: 10.1016/J.Jalz.2013.05.095  0.322
2013 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Ances B, Sullivan C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, ... ... Fox N, et al. IC-P-082: Disrupted functional connectivity in autosomal dominant Alzheimer's disease demonstrates network specificity and precedes brain volume loss: Findings from DIAN Alzheimer's & Dementia. 9: P49-P50. DOI: 10.1016/J.Jalz.2013.05.079  0.39
2013 Cash D, Ridgway G, Modat M, Ryan N, Kinnunen K, Cardoso J, Benzinger T, Jack CR, Raichle M, Marcus D, Ringman J, Thompson P, Ghetti B, Salloway S, Sperling R, ... ... Fox N, et al. Dissociating volume and intensity differences in familial Alzheimer's disease Alzheimers & Dementia. 9: 603. DOI: 10.1016/J.Jalz.2013.05.075  0.412
2013 Cash D, Ridgway G, Ryan N, Liang Y, Kinnunen K, Mahoney C, Rossor M, Ourselin S, Fox N. Comparison of local grey matter volume in familial and sporadic Alzheimer’s disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.074  0.345
2013 Kinnunen K, Ridgway G, Cash D, Leite AB, Finnegan S, Daga P, Cardoso M, Ryan N, Espak M, Rossor M, Ourselin S, Fox N. Abnormalities of fronto-striato-thalamic tract structure and effective connectivity in familial Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.351  0.407
2013 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Ances B, Sullivan C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, ... ... Fox N, et al. O4-03-03: Disrupted functional connectivity in autosomal dominant Alzheimer's disease demonstrates network specificity and precedes brain volume loss: Findings from the Dominantly Inherited Alzheimer Network Alzheimer's & Dementia. 9: P684-P685. DOI: 10.1016/J.Jalz.2013.04.348  0.38
2013 Slattery C, Uphill J, Adamson G, Campbell T, Druyeh R, Lorna H, Nicholas J, Mahoney C, Beck J, Fox N, Schott J, Mead S. TREM2 variants and young-onset Alzheimer's disease: A study of clinical phenotype Alzheimers & Dementia. 9: 519. DOI: 10.1016/J.Jalz.2013.04.241  0.439
2013 Leung K, Schott J, Bartlett J, Fox N. Association between brain atrophy rates from MRI and future cognitive decline Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.106  0.337
2013 Manning E, Barnes J, Cash D, Bartlett J, Leung K, Ourselin S, Fox N. APOE-ε4 is associated with increased hippocampal atrophy rates in Alzheimer's disease Alzheimers & Dementia. 9: 5. DOI: 10.1016/J.Jalz.2013.04.020  0.435
2013 Kinnunen K, Ryan N, Cash D, Leite AB, Finnegan S, Cardoso M, Leung K, Modat M, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Ringman J, Ghetti B, ... ... Fox N, et al. Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.017  0.391
2012 Keihaninejad S, Ryan NS, Malone IB, Modat M, Cash D, Ridgway GR, Zhang H, Fox NC, Ourselin S. The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease. Plos One. 7: e45996. PMID 23139736 DOI: 10.1371/Journal.Pone.0045996  0.377
2012 Fox N. When, where, and how does Alzheimer's disease start? The Lancet. Neurology. 11: 1017-8. PMID 23137950 DOI: 10.1016/S1474-4422(12)70256-9  0.437
2012 Mahoney CJ, Downey LE, Ridgway GR, Beck J, Clegg S, Blair M, Finnegan S, Leung KK, Yeatman T, Golden H, Mead S, Rohrer JD, Fox NC, Warren JD. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimer's Research & Therapy. 4: 41. PMID 23006986 DOI: 10.1186/Alzrt144  0.411
2012 Filippi M, Agosta F, Barkhof F, Dubois B, Fox NC, Frisoni GB, Jack CR, Johannsen P, Miller BL, Nestor PJ, Scheltens P, Sorbi S, Teipel S, Thompson PM, Wahlund LO, et al. EFNS task force: the use of neuroimaging in the diagnosis of dementia. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: e131-40, 1487-501. PMID 22900895 DOI: 10.1111/J.1468-1331.2012.03859.X  0.431
2012 Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753  0.458
2012 Ridgway GR, Lehmann M, Barnes J, Rohrer JD, Warren JD, Crutch SJ, Fox NC. Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology. 79: 80-4. PMID 22722624 DOI: 10.1212/Wnl.0B013E31825Dce28  0.395
2012 Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jäger HR. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1754-62. PMID 22488922 DOI: 10.1002/Mds.24968  0.356
2012 Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2: a006213. PMID 22474610 DOI: 10.1101/Cshperspect.A006213  0.423
2012 Rohrer JD, Clarkson MJ, Kittus R, Rossor MN, Ourselin S, Warren JD, Fox NC. Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. Journal of Alzheimer's Disease : Jad. 30: 407-11. PMID 22406442 DOI: 10.3233/Jad-2012-111556  0.378
2012 Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain : a Journal of Neurology. 135: 736-50. PMID 22366791 DOI: 10.1093/Brain/Awr361  0.362
2012 Lehmann M, Barnes J, Ridgway GR, Ryan NS, Warrington EK, Crutch SJ, Fox NC. Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 502-12. PMID 22365384 DOI: 10.1016/J.Jalz.2011.09.225  0.447
2012 Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. The Lancet. Neurology. 11: 241-9. PMID 22305802 DOI: 10.1016/S1474-4422(12)70015-7  0.354
2012 Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, Scahill RI, Tabrizi SJ, Ourselin S, Fox NC, Alexander DC. An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. Neuroimage. 60: 1880-9. PMID 22281676 DOI: 10.1016/J.Neuroimage.2012.01.062  0.42
2012 Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P. Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial. Journal of Alzheimer's Disease : Jad. 29: 459-69. PMID 22269160 DOI: 10.3233/Jad-2011-111616  0.394
2012 Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. The Lancet. Neurology. 11: 170-8. PMID 22265212 DOI: 10.1016/S1474-4422(11)70289-7  0.427
2012 Leung KK, Ridgway GR, Ourselin S, Fox NC. Consistent multi-time-point brain atrophy estimation from the boundary shift integral. Neuroimage. 59: 3995-4005. PMID 22056457 DOI: 10.1016/J.Neuroimage.2011.10.068  0.421
2012 Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, ... ... Fox N, et al. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 377-87. PMID 22027014 DOI: 10.3233/Jad-2011-110824  0.406
2012 Kennedy J, Lehmann M, Sokolska MJ, Archer H, Warrington EK, Fox NC, Crutch SJ. Visualizing the emergence of posterior cortical atrophy. Neurocase. 18: 248-57. PMID 22026812 DOI: 10.1080/13554794.2011.588180  0.33
2012 Alner K, Hyare H, Mead S, Rudge P, Wroe S, Rohrer JD, Ridgway GR, Ourselin S, Clarkson M, Hunt H, Fox NC, Webb T, Collinge J, Cipolotti L. Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 109-14. PMID 21849340 DOI: 10.1136/Jnnp-2011-300167  0.363
2012 Ryan NS, Bastos-Leite AJ, Rohrer JD, Werring DJ, Fox NC, Rossor MN, Schott JM. Cerebral microbleeds in familial Alzheimer's disease. Brain : a Journal of Neurology. 135: e201; author reply e. PMID 21685457 DOI: 10.1093/Brain/Awr126  0.437
2012 Lehmann M, Koedam EL, Barnes J, Bartlett JW, Ryan NS, Pijnenburg YA, Barkhof F, Wattjes MP, Scheltens P, Fox NC. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiology of Aging. 33: 627.e1-627.e12. PMID 21596458 DOI: 10.1016/J.Neurobiolaging.2011.04.003  0.421
2012 Anderson VM, Schott JM, Bartlett JW, Leung KK, Miller DH, Fox NC. Gray matter atrophy rate as a marker of disease progression in AD Neurobiology of Aging. 33: 1194-1202. PMID 21163551 DOI: 10.1016/J.Neurobiolaging.2010.11.001  0.417
2012 Shakespeare TJ, Crutch SJ, Fox NC. Posterior cortical atrophy: advice for diagnosis and implications for management Neurodegenerative Disease Management. 2: 599-607. DOI: 10.2217/Nmt.12.61  0.402
2012 Mahoney C, Rossor MN, Fox NC, Warren JD. 019 Profiles of white matter degeneration in frontotemporal dementia Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2011-301993.61  0.394
2012 Ryan N, Biessels G, Bastos-Leite A, Beck J, Mead S, Morris H, Schott JM, Rossor MN, Fox NC. White Matter Lesions In Familial Alzheimer'S Disease: Evidence For Influence Of Mutation Position On Amyloid Angiopathy? Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2011-301993.1  0.377
2012 Fox N. 23 MRI in the evaluation of therapeutic effects in clinical trials in early and presymptomatic AD Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.041  0.348
2012 Ryan N, Liang Y, Beck J, Mead S, Rossor M, Fox N. Clinical spectrum of familial Alzheimer's disease in 100 cases Alzheimers & Dementia. 8: 262. DOI: 10.1016/J.Jalz.2012.05.697  0.407
2012 Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655  0.386
2012 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, et al. O2-06-01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Alzheimer's & Dementia. 8: P244-P245. DOI: 10.1016/J.Jalz.2012.05.654  0.385
2012 Burns L, Rueckert D, Bhagwagar Z, Donohue M, Wolz R, Tiller J, Soares H, l'Italien G, Coric V, Hayes W, Fox N, Berman R. A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild-to-moderate Alzheimer's disease Alzheimers & Dementia. 8: 408. DOI: 10.1016/J.Jalz.2012.05.2037  0.367
2012 Benzinger T, Blazey T, Ances B, Raichle M, Ances B, Snyder A, Su Y, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Fox N, et al. IC-P-128: Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study Alzheimer's & Dementia. 8: P68-P69. DOI: 10.1016/j.jalz.2012.05.1858  0.405
2012 Schott J, Crutch S, Uphill J, Ryan N, Shakespeare T, Lehmann M, Yong K, Rossor M, Fox N, Mead S. Genetic risk factors for posterior cortical atrophy may be distinct from late-onset Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1810  0.388
2012 Kinnunen K, Cash D, Leung K, Liang Y, Cardoso M, Modat M, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, ... ... Fox N, et al. Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.172  0.422
2012 Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Fox N, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132  0.462
2012 Liang Y, Crutch S, Nicholas J, Ryan N, Warrington E, Shakespeare T, Yeatman T, Rossor M, Fox N. Longitudinal presymptomatic cognitive changes in individuals at risk of familial Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1167  0.396
2012 Keihaninejad S, Zhang H, Ryan N, Malone I, Frost C, Cardoso M, Modat M, Thornton J, Cash D, Ourselin S, Fox N. White matter tract changes in mild-to-moderate Alzheimer's disease revealed by tensor-based registration analyses of diffusion tensor imaging Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.079  0.382
2012 Keihaninejad S, Zhang H, Ryan N, Malone I, Frost C, Cardoso M, Modat M, Mancini L, Thornton J, Cash D, Ourselin S, Fox N. Longitudinal changes in fiber tract integrity in Alzheimer's disease: A serial diffusion tensor imaging study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.078  0.353
2012 Kinnunen K, Cash D, Liang Y, Leung K, Cardoso M, Modat M, Malone I, Yeatman T, Nicholas J, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, ... ... Fox N, et al. Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Alzheimers & Dementia. 8: 23. DOI: 10.1016/J.Jalz.2012.05.064  0.415
2012 Cash D, Liang Y, Leung K, Ryan N, Modat M, Cardoso M, Yeatman T, Crutch S, Woodward F, Malone I, Bartlett J, Kinnunen K, Rossor M, Ourselin S, Fox N. Rates of brain and hippocampal atrophy in presymptomatic familial Alzheimer's disease: Acceleration and mutation effects Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.053  0.417
2012 Cash D, Ridgway G, Ryan N, Kinnunen K, Yeatman T, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, Salloway S, ... ... Fox N, et al. A voxel-based morphometry study of volumetric MRI in familial Alzheimer’s disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.052  0.404
2012 Mahoney CJ, Rohrer JD, Beck J, Shakespeare T, Yeatman T, Schot JM, Fox N, Rossor MN, Hardy J, Collinge J, Mead S, Warren JD. The neuroimaging phenotype of frontotemporal dementia with the C9ORF72 hexanucletoide repeat expansion Alzheimers & Dementia. 8: 8. DOI: 10.1016/J.Jalz.2012.05.025  0.376
2012 Bateman R, Benzinger T, Cairns N, Fagan A, Goate A, Marcus D, Storandt M, Xiong C, Buckles V, Holtzman D, Moulder K, Oliver A, Santacruz A, Fox N, Ghetti B, et al. Presymptomatic Alzheimer's disease in the Dominantly Inherited Alzheimer's Network (DIAN) Alzheimers & Dementia. 8: 4. DOI: 10.1016/J.Jalz.2012.05.015  0.411
2011 Schott JM, Warren JD, Barkhof F, Rossor MN, Fox NC. Suspected early dementia. Bmj (Clinical Research Ed.). 343: d5568. PMID 21933826 DOI: 10.1136/Bmj.D5568  0.365
2011 Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E, Troakes C, Al-Sarraj S, King A, Borroni B, Clarkson MJ, ... ... Fox NC, et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain : a Journal of Neurology. 134: 2565-81. PMID 21908872 DOI: 10.1093/Brain/Awr198  0.447
2011 Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, et al. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 514-20. PMID 21889115 DOI: 10.1016/J.Jalz.2010.12.010  0.425
2011 Sims R, Dwyer S, Harold D, Gerrish A, Hollingworth P, Chapman J, Jones N, Abraham R, Ivanov D, Pahwa JS, Moskvina V, Dowzell K, Thomas C, Stretton A, Lovestone S, ... ... Fox N, et al. No evidence that extended tracts of homozygosity are associated with Alzheimer's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 764-71. PMID 21812096 DOI: 10.1002/Ajmg.B.31216  0.425
2011 Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, ... ... Fox NC, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain : a Journal of Neurology. 134: 2456-77. PMID 21810890 DOI: 10.1093/Brain/Awr179  0.397
2011 Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP. Visual assessment of posterior atrophy development of a MRI rating scale. European Radiology. 21: 2618-25. PMID 21805370 DOI: 10.1007/S00330-011-2205-4  0.4
2011 Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 474-485.e4. PMID 21784356 DOI: 10.1016/J.Jalz.2011.04.007  0.431
2011 Lashley T, Rohrer JD, Bandopadhyay R, Fry C, Ahmed Z, Isaacs AM, Brelstaff JH, Borroni B, Warren JD, Troakes C, King A, Al-Saraj S, Newcombe J, Quinn N, Ostergaard K, ... ... Fox NC, et al. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain : a Journal of Neurology. 134: 2548-64. PMID 21752791 DOI: 10.1093/Brain/Awr160  0.327
2011 Clarkson MJ, Cardoso MJ, Ridgway GR, Modat M, Leung KK, Rohrer JD, Fox NC, Ourselin S. A comparison of voxel and surface based cortical thickness estimation methods. Neuroimage. 57: 856-65. PMID 21640841 DOI: 10.1016/J.Neuroimage.2011.05.053  0.308
2011 Mahoney CJ, Rohrer JD, Goll JC, Fox NC, Rossor MN, Warren JD. Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1274-8. PMID 21531705 DOI: 10.1136/Jnnp.2010.235473  0.331
2011 Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 270-9. PMID 21514249 DOI: 10.1016/j.jalz.2011.03.008  0.337
2011 Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, ... ... Fox NC, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics. 43: 429-35. PMID 21460840 DOI: 10.1038/Ng.803  0.304
2011 Cardoso MJ, Clarkson MJ, Ridgway GR, Modat M, Fox NC, Ourselin S. LoAd: A locally adaptive cortical segmentation algorithm Neuroimage. 56: 1386-1397. PMID 21316470 DOI: 10.1016/J.Neuroimage.2011.02.013  0.365
2011 Fox NC, Ridgway GR, Schott JM. Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials. Neuroimage. 57: 15-8. PMID 21296168 DOI: 10.1016/J.Neuroimage.2011.01.077  0.333
2011 Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimer's Research & Therapy. 3: 1. PMID 21211070 DOI: 10.1186/Alzrt59  0.46
2011 van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE É›4 allele. The Lancet. Neurology. 10: 280-8. PMID 21185234 DOI: 10.1016/S1474-4422(10)70306-9  0.411
2011 Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/J.Pneurobio.2010.11.005  0.419
2011 Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet. Neurology. 10: 31-42. PMID 21130037 DOI: 10.1016/S1474-4422(10)70276-3  0.429
2011 Knight WD, Okello AA, Ryan NS, Turkheimer FE, Rodríguez Martinez de Llano S, Edison P, Douglas J, Fox NC, Brooks DJ, Rossor MN. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain : a Journal of Neurology. 134: 293-300. PMID 21084313 DOI: 10.1093/Brain/Awq310  0.3
2011 Seelaar H, Rohrer JD, Pijnenburg YAL, Fox NC, Swieten JCv. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review Journal of Neurology, Neurosurgery, and Psychiatry. 82: 476-486. PMID 20971753 DOI: 10.1136/Jnnp.2010.212225  0.421
2011 Stevens JC, Beck J, Lukic A, Ryan N, Abbs S, Collinge J, Fox NC, Mead S. Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1054-7. PMID 20802216 DOI: 10.1136/Jnnp.2009.199653  0.407
2011 Rohrer JD, Lashley T, Holton J, Revesz T, Urwin H, Isaacs AM, Fox NC, Rossor MN, Warren J. The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1405-7. PMID 20639383 DOI: 10.1136/Jnnp.2010.214437  0.386
2011 Knight WD, Kim LG, Douiri A, Frost C, Rossor MN, Fox NC. Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiology of Aging. 32: 1765-73. PMID 20005601 DOI: 10.1016/J.Neurobiolaging.2009.11.013  0.456
2011 Lehmann M, Crutch SJ, Ridgway GR, Ridha BH, Barnes J, Warrington EK, Rossor MN, Fox NC. Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease. Neurobiology of Aging. 32: 1466-76. PMID 19781814 DOI: 10.1016/J.Neurobiolaging.2009.08.017  0.415
2011 Lehmann M, Rohrer JD, Clarkson MJ, Ridgway GR, Scahill RI, Modat M, Warren JD, Ourselin S, Barnes J, Rossor MN, Fox NC. Patterns of cortical thickness in pathologically-confirmed typical and atypical Alzheimer's disease Advances in Alzheimer's Disease. 2: 57-67. DOI: 10.3233/978-1-60750-793-2-57  0.311
2011 Ryan NS, Okello A, Knight WD, Lehmann M, Malone I, Clarkson M, Bartlett J, Ridgway G, Mancini L, Thornton J, Ourselin S, Brooks D, Rossor M, Fox N. Early subcortical amyloid deposition in familial Alzheimer's disease is accompanied by changes in tissue volume and diffusivity Journal of Neurology, Neurosurgery, and Psychiatry. 82. DOI: 10.1136/Jnnp.2010.235572.6  0.373
2011 Mahoney CJ, Malone I, Buckley A, Rosser MN, Fox NC, Warren JD. 05 White matter tract changes in the primary progressive aphasias Journal of Neurology, Neurosurgery, and Psychiatry. 82. DOI: 10.1136/Jnnp.2010.235572.5  0.347
2011 Ryan N, Rossor MN, Fox NC. P.01 Characterising the clinical phenotype of familial Alzheimer's disease (FAD) Journal of Neurology, Neurosurgery, and Psychiatry. 82. DOI: 10.1136/Jnnp-2011-300645.1  0.378
2011 Ryan N, Biessels G, Bastos-Leite A, Mead S, Rossor M, Fox N. White matter lesions in familial Alzheimer's disease: evidence for influence of mutation position on amyloid angiopathy? Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.666  0.392
2011 Rohrer J, Clarkson M, Kittus R, Rossor M, Ourselin S, Warren J, Fox N. Tracking progression with serial MRI in the language variants of frontotemporal lobar degeneration Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.623  0.373
2011 Barnes J, Visser PJ, Scheltens P, Lehmann M, Bartlett J, Koedam E, Fox N, Ridgway G, Schott J. Which biomarkers are useful in predicting converters to Alzheimer's Disease from MCI at 12 or 36 months from baseline? Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.339  0.401
2011 Thompson A, Mahoney C, Ryan N, Bajaj N, Lukic A, Carswell C, Hyare H, Gopalakrishnan G, Mummery C, Collinge J, Rudge P, Fox N, Mead S. Prion disease masquerading as Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2196  0.418
2011 Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Xie S, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis A, Josephs KA, Boeve BF, Kertesz A, Seeley WW, ... ... Fox NC, et al. P4-166: Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC) Alzheimer's & Dementia. 7: S761-S762. DOI: 10.1016/J.Jalz.2011.05.2188  0.322
2011 Fox N. DIAN: MRI of familial Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1961  0.432
2011 Barnes J, Bartlett J, Malone I, Blair M, Fox N, Schott J. Targeted recruitment using CSF biomarkers: Implications for Alzheimer's disease trials Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.151  0.401
2011 Manning E, Ridgeway G, Malone I, Barnes J, Schott J, Fox N. Structural correlates of CSF Abeta1-42 in controls, mild cognitive impairment and Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.125  0.409
2011 Ridgway G, Barnes J, Pepple T, Fox N. Estimation of total intracranial volume - a comparison of methods Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.099  0.313
2011 Clarkson M, Cardoso J, Modat M, Ridgway G, Leung K, Rohrer J, Ourselin S, Fox N. A comparative study of voxel and surface-based cortical thickness methods in frontotemporal dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.082  0.314
2011 Keihaninejad S, Ryan N, Malone I, Ourselin S, Fox N. White matter tract abnormalities in mild to moderate Alzheimer's disease revealed by region-of-interest analyses of diffusion tensor imaging Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.068  0.39
2011 Keihaninejad S, Ryan N, Malone I, Leung K, Hyare H, Ourselin S, Fox N. Automated segmentation of the thalamus for measurement of MR diffusion indices: evaluation and application to familial Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.067  0.381
2011 Leung K, Mahoney C, Barnes J, Ourselin S, Fox N. Automated quantification of hippocampal asymmetry in MRI in semantic dementia and Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.036  0.474
2011 Lehmann M, Koedam E, Barnes J, Jonathan B, Pijnenburg Y, Barkhof F, Wattjes M, Scheltens P, Fox N. Pathologically proven Alzheimer's disease without medial temporal lobe atrophy: The importance of posterior cerebral atrophy Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.035  0.44
2011 Barnes J, Carmichael O, Leung K, Schwarz C, Ridgway G, Bartlett J, Malone I, Schott J, Rossor M, Biessels G, DeCarli C, Fox N. The independent effects of white matter hyperintensity volume and cerebrospinal fluid amyloid levels on brain atrophy Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.014  0.444
2010 Schott JM, Bartlett JW, Fox NC, Barnes J. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Annals of Neurology. 68: 825-34. PMID 21181717 DOI: 10.1002/Ana.22315  0.434
2010 Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R, Gerrish A, Pahwa JS, Jones N, Stretton A, Morgan AR, ... ... Fox N, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. Plos One. 5: e13950. PMID 21085570 DOI: 10.1371/Journal.Pone.0013950  0.349
2010 Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, et al. Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. Neurology. 9: 1118-27. PMID 20934914 DOI: 10.1016/S1474-4422(10)70223-4  0.441
2010 Leung KK, Shen KK, Barnes J, Ridgway GR, Clarkson MJ, Fripp J, Salvado O, Meriaudeau F, Fox NC, Bourgeat P, Ourselin S. Increasing power to predict mild cognitive impairment conversion to Alzheimer's disease using hippocampal atrophy rate and statistical shape models. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 13: 125-32. PMID 20879307  0.332
2010 Schott JM, Frost C, MacManus DG, Ibrahim F, Waldman AD, Fox NC. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study. Brain : a Journal of Neurology. 133: 3315-22. PMID 20739347 DOI: 10.1093/Brain/Awq208  0.405
2010 Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. The Lancet. Neurology. 9: 793-806. PMID 20650401 DOI: 10.1016/S1474-4422(10)70159-9  0.434
2010 Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiology of Aging. 31: 1452-62, 1462.e1-2. PMID 20620665 DOI: 10.1016/J.Neurobiolaging.2010.04.011  0.444
2010 Wild EJ, Henley SM, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 888-95. PMID 20461806 DOI: 10.1002/Mds.22969  0.39
2010 Jack CR, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 212-20. PMID 20451869 DOI: 10.1016/J.Jalz.2010.03.004  0.387
2010 Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage. 51: 1345-59. PMID 20230901 DOI: 10.1016/J.Neuroimage.2010.03.018  0.412
2010 Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, Schott JM, Nalls MA, Ribeiro H, Santiago B, Fox NC, Oliveira C, Collinge J, Mead S, Singleton A, Hardy J. Genetic variability in CLU and its association with Alzheimer's disease. Plos One. 5: e9510. PMID 20209083 DOI: 10.1371/Journal.Pone.0009510  0.346
2010 Barnes J, Mitchell LA, Kennedy J, Bastos-Leite AJ, Barker S, Lehmann M, Nordstrom RC, Frost C, Smith JR, Garde E, Rossor MN, Fox NC. Does registration of serial MRI improve diagnosis of dementia? Neuroradiology. 52: 987-95. PMID 20195590 DOI: 10.1007/S00234-010-0665-X  0.364
2010 Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. The Lancet. Neurology. 9: 363-72. PMID 20189881 DOI: 10.1016/S1474-4422(10)70043-0  0.343
2010 Lehmann M, Rohrer JD, Clarkson MJ, Ridgway GR, Scahill RI, Modat M, Warren JD, Ourselin S, Barnes J, Rossor MN, Fox NC. Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: 587-98. PMID 20182057 DOI: 10.3233/Jad-2010-1401  0.44
2010 Gordon E, Rohrer JD, Kim LG, Omar R, Rossor MN, Fox NC, Warren JD. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology. 74: 666-73. PMID 20177120 DOI: 10.1212/Wnl.0B013E3181D1A879  0.435
2010 Hyare H, Wroe S, Siddique D, Webb T, Fox NC, Stevens J, Collinge J, Yousry T, Thornton JS. Brain-water diffusion coefficients reflect the severity of inherited prion disease. Neurology. 74: 658-65. PMID 20177119 DOI: 10.1212/Wnl.0B013E3181D0Cc47  0.423
2010 Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. Ajnr. American Journal of Neuroradiology. 31: 1036-41. PMID 20150305 DOI: 10.3174/Ajnr.A2018  0.373
2010 Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nature Reviews. Neurology. 6: 67-77. PMID 20139996 DOI: 10.1038/Nrneurol.2009.215  0.452
2010 Archer HA, Kennedy J, Barnes J, Pepple T, Boyes R, Randlesome K, Clegg S, Leung KK, Ourselin S, Frost C, Rossor MN, Fox NC. Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease. International Journal of Geriatric Psychiatry. 25: 1119-26. PMID 20084620 DOI: 10.1002/Gps.2440  0.395
2010 Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC, Rossor MN, Warren JD. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage. 53: 1070-6. PMID 20045477 DOI: 10.1016/J.Neuroimage.2009.12.088  0.386
2010 Henley SM, Ridgway GR, Scahill RI, Klöppel S, Tabrizi SJ, Fox NC, Kassubek J. Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease. Ajnr. American Journal of Neuroradiology. 31: 711-9. PMID 20037137 DOI: 10.3174/Ajnr.A1939  0.324
2010 Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR, Weiner MW, Fox NC, Ourselin S. Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage. 50: 516-23. PMID 20034579 DOI: 10.1016/J.Neuroimage.2009.12.059  0.446
2010 Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, Bombois S, Brettschneider J, Fox NC, von Arnim CA, Teunissen C, Pijnenburg Y, Riepe MW, Otto M, Tumani H, Scheltens P, et al. An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels. Experimental Neurology. 223: 432-8. PMID 20005225 DOI: 10.1016/J.Expneurol.2009.11.010  0.377
2010 Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 756-63. PMID 19955112 DOI: 10.1136/Jnnp.2009.190702  0.393
2010 Lehmann M, Douiri A, Kim LG, Modat M, Chan D, Ourselin S, Barnes J, Fox NC. Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements. Neuroimage. 49: 2264-2274. PMID 19874902 DOI: 10.1016/J.Neuroimage.2009.10.056  0.384
2010 Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. European Radiology. 20: 674-82. PMID 19760240 DOI: 10.1007/S00330-009-1581-5  0.579
2010 Lahiri N, Tabrizi SJ, Kennard C, Durr A, Leavitt BR, Fox N, Roos RA. POMD07 Quantitative assessment of biological and clinical manifestations of Huntington's disease before and after diagnosis--the TRACK-HD study Journal of Neurology, Neurosurgery & Psychiatry. 81: e59-e59. DOI: 10.1136/Jnnp.2010.226340.167  0.413
2010 Massey L, Paviour D, Fox N, Micallef C, Burn D, Holton J, Lees A, Jager H, Revesz T, O'Sullivan S. Blinded Analysis Of Conventional Mri In A Cohort Of Pathologically Confirmed Parkinsonian Illnesses Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.226340.161  0.358
2010 Mahoney C, Rossor MN, Rohrer JD, Warren JD, Fox NC, Goll JC. POD07 Tinnitus and hyperacusis in semantic dementia Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.226340.107  0.33
2010 Ridha BH, Ridgway G, Symms M, Barnes J, Fox NC. Statistical Parametric Mapping Analysis of Magnetization Transfer Ratio in Alzheimer's Disease: Comparison With Volumetric Imaging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.119  0.372
2010 Ryan NS, Okello A, Knight WD, Lehmann M, Malone I, Clarkson MJ, Bartlett J, Ridgway GR, Mancini L, Thornton J, Ourselin S, Brooks DJ, Rossor MN, Fox NC. Early subcortical amyloid deposition in familial Alzheimer's disease is accompanied by changes in tissue volume and diffusivity Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.429  0.393
2010 Whitwell JL, Gunter JL, Weigand SD, Przybelski SA, Senjem ML, Fox NC, Jack CR. Combining Scans Performed at Different Field Strengths in VBM Studies of Alzheimer's Disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.126  0.383
2010 Barnes J, Leung KK, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Fox NC, Ourselin S. Automated Hippocampal Volumes and Atrophy Rates can Distinguish Between Stable Mild Cognitive Impairment and Converters to Alzheimer's Disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.078  0.419
2010 Ridha BH, Vita ED, Thornton JS, Fox NC, Jager HR. Diffusion-Weighted Imaging in Alzheimer's Disease: Comparison with Volumetric Measurements Using Voxel-Based Analysis Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.076  0.382
2010 Barnes J, Bartlett JW, Blair M, Gordon E, Macdonald K, Pepple T, Fox NC. Discriminating AD from controls and other neurodegenerative diseases: A cross-sectional and longitudinal MRI study Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.034  0.389
2009 Knight WD, Ahsan RL, Jackson J, Cipolotti L, Warrington EK, Fox NC, Rossor MN. Pure progressive amnesia and the APPV717G mutation. Alzheimer Disease and Associated Disorders. 23: 410-4. PMID 19950418 DOI: 10.1097/Wad.0B013E31819Cb7F3  0.437
2009 Gutiérrez-Galve L, Lehmann M, Hobbs NZ, Clarkson MJ, Ridgway GR, Crutch S, Ourselin S, Schott JM, Fox NC, Barnes J. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 28: 476-85. PMID 19940480 DOI: 10.1159/000258100  0.35
2009 Ryan NS, Fox NC. Imaging Biomarkers in Alzheimer's Disease Annals of the New York Academy of Sciences. 1180: 20-27. PMID 19906257 DOI: 10.1111/J.1749-6632.2009.05062.X  0.4
2009 Wild EJ, Fox NC. Serial volumetric MRI in Parkinsonian disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 24: S691-8. PMID 19877198 DOI: 10.1002/Mds.22500  0.422
2009 Henneman WJ, Vrenken H, Barnes J, Sluimer IC, Verwey NA, Blankenstein MA, Klein M, Fox NC, Scheltens P, Barkhof F, van der Flier WM. Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. Neurology. 73: 935-40. PMID 19770469 DOI: 10.1212/Wnl.0B013E3181B879Ac  0.461
2009 Lloyd SE, Rossor M, Fox N, Mead S, Collinge J. HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q. Bmc Medical Genetics. 10: 90. PMID 19754925 DOI: 10.1186/1471-2350-10-90  0.391
2009 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Fox N, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics. 41: 1088-93. PMID 19734902 DOI: 10.1038/Ng.440  0.329
2009 Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology. 8: 791-801. PMID 19646924 DOI: 10.1016/S1474-4422(09)70170-X  0.405
2009 Sluimer JD, van der Flier WM, Karas GB, van Schijndel R, Barnes J, Boyes RG, Cover KS, Olabarriaga SD, Fox NC, Scheltens P, Vrenken H, Barkhof F. Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. European Radiology. 19: 2826-33. PMID 19618189 DOI: 10.1007/S00330-009-1512-5  0.421
2009 Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, NÃ¥gren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 73: 754-60. PMID 19587325 DOI: 10.1212/Wnl.0B013E3181B23564  0.413
2009 Hobbs NZ, Henley SM, Wild EJ, Leung KK, Frost C, Barker RA, Scahill RI, Barnes J, Tabrizi SJ, Fox NC. Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease. Neuroimage. 47: 1659-65. PMID 19523522 DOI: 10.1016/J.Neuroimage.2009.06.003  0.357
2009 Ryan NS, Fox NC. Alzheimer disease: Visual rating of atrophy aids diagnostic accuracy Nature Reviews Neurology. 5: 243-244. PMID 19488081 DOI: 10.1038/Nrneurol.2009.52  0.419
2009 Clarkson MJ, Ourselin S, Nielsen C, Leung KK, Barnes J, Whitwell JL, Gunter JL, Hill DL, Weiner MW, Jack CR, Fox NC. Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage. 47: 1506-13. PMID 19477282 DOI: 10.1016/J.Neuroimage.2009.05.045  0.392
2009 Rohrer JD, Warren JD, Modat M, Ridgway GR, Douiri A, Rossor MN, Ourselin S, Fox NC. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology. 72: 1562-9. PMID 19414722 DOI: 10.1212/Wnl.0B013E3181A4124E  0.334
2009 Barnes J, Ourselin S, Fox NC. Clinical application of measurement of hippocampal atrophy in degenerative dementias Hippocampus. 19: 510-516. PMID 19405145 DOI: 10.1002/Hipo.20617  0.451
2009 Omar R, Sampson EL, Loy CT, Mummery CJ, Fox NC, Rossor MN, Warren JD. Delusions in frontotemporal lobar degeneration. Journal of Neurology. 256: 600-7. PMID 19365594 DOI: 10.1007/S00415-009-0128-7  0.381
2009 Chan D, Anderson V, Pijnenburg Y, Whitwell J, Barnes J, Scahill R, Stevens JM, Barkhof F, Scheltens P, Rossor MN, Fox NC. The clinical profile of right temporal lobe atrophy. Brain : a Journal of Neurology. 132: 1287-98. PMID 19297506 DOI: 10.1093/Brain/Awp037  0.324
2009 Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology. 72: 999-1007. PMID 19289740 DOI: 10.1212/01.Wnl.0000344568.09360.31  0.345
2009 Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, Barker RA, Fox NC, Tabrizi SJ. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. Journal of Neurology. 256: 203-12. PMID 19266143 DOI: 10.1007/S00415-009-0052-X  0.397
2009 Henley SM, Wild EJ, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 932-6. PMID 19243073 DOI: 10.1002/Mds.22485  0.406
2009 Ridgway GR, Omar R, Ourselin S, Hill DL, Warren JD, Fox NC. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage. 44: 99-111. PMID 18848632 DOI: 10.1016/J.Neuroimage.2008.08.045  0.353
2009 Barnes J, Bartlett JW, Pol LAvd, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC. A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiology of Aging. 30: 1711-1723. PMID 18346820 DOI: 10.1016/J.Neurobiolaging.2008.01.010  0.4
2009 Klppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Ashburner J, Frackowiak RSJ. A plea for confidence intervals and consideration of generalizability in diagnostic studies Brain. 132: e102. DOI: 10.1093/Brain/Awn091  0.309
2009 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Fox N, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 41: 1156-1156. DOI: 10.1038/Ng1009-1156D  0.351
2009 Lehmann M, Clarkson MJ, Rohrer JD, Scahill RI, Modat M, Warren JD, Ourselin S, Rossor MN, Barnes J, Fox NC. Characteristic patterns of cortical thickness in pathologically-confirmed Alzheimer's disease and frontotemporal lobar degeneration Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.05.561  0.43
2009 Macdonald K, Leung KK, Nielsen C, Ourselin S, Weiner MW, Schuff N, Barnes J, Fox NC. Can hippocampal or temporal horn atrophy rates predict future conversion to Alzheimer's disease? Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.05.055  0.408
2009 Fox N. Tracking disease progression with volumetric MRI Alzheimers & Dementia. 5: 3. DOI: 10.1016/J.Jalz.2009.05.008  0.375
2008 Rohrer JD, McNaught E, Foster J, Clegg SL, Barnes J, Omar R, Warrington EK, Rossor MN, Warren JD, Fox NC. Tracking progression in frontotemporal lobar degeneration: serial MRI in semantic dementia. Neurology. 71: 1445-51. PMID 18955688 DOI: 10.1212/01.Wnl.0000327889.13734.Cd  0.397
2008 Klöppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR, Ashburner J, Frackowiak RS. Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain : a Journal of Neurology. 131: 2969-74. PMID 18835868 DOI: 10.1093/Brain/Awn239  0.406
2008 Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiology of Disease. 32: 412-9. PMID 18786637 DOI: 10.1016/J.Nbd.2008.08.001  0.35
2008 Rohrer JD, Warren JD, Barnes J, Mead S, Beck J, Pepple T, Boyes R, Omar R, Collinge J, Stevens JM, Warrington EK, Rossor MN, Fox NC. Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nature Clinical Practice. Neurology. 4: 455-60. PMID 18648346 DOI: 10.1038/Ncpneuro0869  0.385
2008 Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F, Vrenken H. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology. 248: 590-8. PMID 18574133 DOI: 10.1148/Radiol.2482070938  0.412
2008 Camara O, Schnabel JA, Ridgway GR, Crum WR, Douiri A, Scahill RI, Hill DL, Fox NC. Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images. Neuroimage. 42: 696-709. PMID 18571436 DOI: 10.1016/J.Neuroimage.2008.04.259  0.372
2008 Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, Flier WMvd. Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors Neurology. 70: 1836-1841. PMID 18458218 DOI: 10.1212/01.Wnl.0000311446.61861.E3  0.403
2008 Rohrer JD, Warren JD, Omar R, Mead S, Beck J, Revesz T, Holton J, Stevens JM, Al-Sarraj S, Pickering-Brown SM, Hardy J, Fox NC, Collinge J, Warrington EK, Rossor MN. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Archives of Neurology. 65: 506-13. PMID 18413474 DOI: 10.1001/Archneur.65.4.506  0.355
2008 Schott JM, Crutch SJ, Frost C, Warrington EK, Rossor MN, Fox NC. Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia. 46: 1732-7. PMID 18395233 DOI: 10.1016/J.Neuropsychologia.2008.02.015  0.453
2008 Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR, Bernstein MA, Britson PJ, Ward CP, Whitwell JL, ... ... Fox NC, et al. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage. 41: 19-34. PMID 18378167 DOI: 10.1016/J.Neuroimage.2008.02.010  0.47
2008 Barnes J, Foster J, Boyes RG, Pepple T, Moore EK, Schott JM, Frost C, Scahill RI, Fox NC. A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage. 40: 1655-71. PMID 18353687 DOI: 10.1016/J.Neuroimage.2008.01.012  0.368
2008 Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging : Jmri. 27: 685-91. PMID 18302232 DOI: 10.1002/Jmri.21049  0.41
2008 Karas G, Sluimer JD, Goekoop R, Flier WMvd, Rombouts SARB, Vrenken H, Scheltens P, Fox NC, Barkhof F. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease American Journal of Neuroradiology. 29: 944-949. PMID 18296551 DOI: 10.3174/Ajnr.A0949  0.415
2008 Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression. Journal of Neurology. 255: 567-74. PMID 18274807 DOI: 10.1007/S00415-008-0750-9  0.451
2008 Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, Warrington EK, Stevens J, Revesz T, Holton J, Al-Sarraj S, King A, Scahill R, Warren JD, Fox NC, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain : a Journal of Neurology. 131: 706-20. PMID 18234697 DOI: 10.1093/Brain/Awm320  0.363
2008 Klöppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR, Ashburner J, Frackowiak RS. Automatic classification of MR scans in Alzheimer's disease. Brain : a Journal of Neurology. 131: 681-9. PMID 18202106 DOI: 10.1093/Brain/Awm319  0.433
2008 Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DL, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, DeCarli C, Jack CR, Fox NC, et al. Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage. 39: 1752-62. PMID 18063391 DOI: 10.1016/J.Neuroimage.2007.10.026  0.347
2008 Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, Warren JD. Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain : a Journal of Neurology. 131: 8-38. PMID 17947337 DOI: 10.1093/Brain/Awm251  0.34
2008 Barnes J, Scahill RI, Frost C, Schott JM, Rossor MN, Fox NC. Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging. Neurobiology of Aging. 29: 1199-203. PMID 17368654 DOI: 10.1016/J.Neurobiolaging.2007.02.011  0.377
2008 Barnes J, Bartlett JW, Pol LAvd, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC. P1-314: A meta-analysis of hippocampal atrophy rates in Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.905  0.424
2008 van der Flier WM, Sluimer J, Karas GB, van Schijndel R, Barnes J, Boyes R, Cover K, Olabarriaga S, Fox NC, Scheltens P, Vrenken H, Barkhof F. P1-302: Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease Alzheimer's & Dementia. 4: T308-T308. DOI: 10.1016/J.Jalz.2008.05.893  0.419
2008 Stonnington CM, Klöppel S, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR, Ashburner J, Frackowiak RSJ. P1-298: Automatic classification of MRI scans in Alzheimer's disease and frontotemporal lobar degeneration Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.888  0.449
2008 Schott JM, MacManus DG, Frost C, Rossor MN, Waldman AD, Fox NC. P1-287: Proton spectroscopy in Alzheimer's disease: A longitudinal multiple time point study Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.877  0.408
2008 Henneman WJ, Vrenken H, Barnes J, Sluimer JD, Van der Flier WM, Fox NC, Scheltens P, Barkhof F. P1-248: Diagnostic utility of cross-sectional and longitudinal hippocampal volumetry in memory clinic patients Alzheimer's & Dementia. 4: T288-T288. DOI: 10.1016/J.Jalz.2008.05.837  0.435
2008 Alexander GE, Hanson KD, Chen K, Reiman EM, Bernstein MA, Kornak J, Schuff NW, Fox NC, Thompson PM, Weiner MW, Jack CR. P1-216: Six month MRI gray matter declines in Alzheimer's dementia evaluated by voxel-based morphometry with multivariate network analysis: Preliminary findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 4: T273-T273. DOI: 10.1016/J.Jalz.2008.05.805  0.467
2008 Rohrer JD, McNaught E, Foster J, Clegg S, Barnes J, Omar R, Rossor M, Warren J, Fox N. O3-06-03: Profiles of longitudinal brain atrophy in semantic dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.452  0.33
2008 Williams J, Abraham R, Morgan A, Sims R, Hollingworth P, O'Donovan M, Owen M, Holmans P, Nikolov I, Moskvina V, Lovestone S, Rubinsztein D, Brayne C, Gill M, Lawlor B, ... ... Fox N, et al. O2-06-01: A powerful, genome-wide association scan for susceptibility genes for late-onset Alzheimer's disease Alzheimer's & Dementia. 4: T143-T143. DOI: 10.1016/J.Jalz.2008.05.349  0.343
2008 Fox NC. PL-01-02: Imaging in dementia: Distinguishing diseases and measuring progression Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.180  0.426
2008 Lehmann M, Douiri A, Barnes J, Chan D, Rossor MN, Fox NC. IC-P3-195: Atrophy patterns in Alzheimer's disease and semantic dementia: A comparison of FreeSurfer and manual measurements Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.139  0.412
2008 McNaught E, Rohrer JD, Omar R, Ahsan L, Rossor MN, Warren JD, Fox NC. P2‐189: Longitudinal atrophy rate as a biomarker of disease progression in frontotemporal lobar degeneration Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1263  0.388
2008 Ahsan L, Rohrer JD, Isaacs A, Nielsen JE, Ostergaard L, Scahill R, Rossor MN, Warren JD, Fox NC, Johannsen P. P2‐183: Generalised brain atrophy predates symptom onset in frontotemporal dementia caused by CHMP2B mutation Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1257  0.339
2008 Lehmann M, Douiri A, Barnes J, Chan D, Rossor MN, Fox NC. P2-038: Atrophy patterns in Alzheimer's disease and semantic dementia: A comparison of FreeSurfer and manual measurements Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1119  0.443
2008 Knight W, Foster J, Ahsan L, Warrington E, Fox N, Rossor M. IC-P3-190: An unusual, APPV717G-associated familial Alzheimer's disease phenotype: Neuropsychological and radiological data Alzheimer's & Dementia. 4: T83-T83. DOI: 10.1016/J.Jalz.2008.05.1113  0.391
2008 Evans MC, Nielsen C, Douiri A, Barnes J, Clegg SL, Lehmann M, Mellow T, McNaught E, Ahsan L, Boyes R, Pepple T, Foster J, Rossor MN, Fox NC. P2-007: Automating the BSI brain atrophy rate calculation: Comparison of using automated and semi-automated brain regions Alzheimer's & Dementia. 4: T367-T368. DOI: 10.1016/J.Jalz.2008.05.1087  0.509
2008 Kennedy J, Barnes J, Archer H, Pepple T, Sluimer JD, Henneman WJP, Rossor MN, Fox NC. IC-P2-109: Medial temporal lobe atrophy and rate of loss predicts future cognitive decline in patients with memory complaints with or without memory deficits: A comparison of methods Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.102  0.421
2008 Evans MC, Barnes J, Clegg SL, Lehmann M, Mellow T, McNaught E, Ahsan L, Boyes R, Pepple T, Foster J, Nielsen C, Rossor MN, Fox NC. IC-P2-095: Rates of whole brain atrophy and ventricular enlargement: Correlations with cognitive performance Alzheimer's & Dementia. 4: T45-T46. DOI: 10.1016/J.Jalz.2008.05.088  0.519
2008 Barnes J, Mitchell LA, Kennedy J, Barker S, Lehmann M, Nordstrom RC, Frost C, Smith JR, Garde E, Rossor MN, Fox NC. AbstractPoster presentation: Imaging posterIC-P1-003: Registration of serial MRI improves diagnosis of dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.016  0.355
2008 Alexander GE, Hanson KD, Chen K, Reiman EM, Bernstein MA, Kornak J, Schuff NW, Fox NC, Thompson PM, Weiner MW, Jack CR. IC-03-06: Six month MRI gray matter declines in Alzheimer's dementia evaluated by voxel-based morphometry with multivariate network analysis: Preliminary findings from the ADNI study Alzheimer's & Dementia. 4: T8-T8. DOI: 10.1016/J.Jalz.2008.05.011  0.386
2007 Barnes J, Foster J, Fox NC. Structural magnetic resonance imaging-derived biomarkers for Alzheimer’s disease Biomarkers in Medicine. 1: 79-92. PMID 20477462 DOI: 10.2217/17520363.1.1.79  0.364
2007 Scahill RI, Fox NC. Longitudinal imaging in dementia British Journal of Radiology. 80. PMID 18445749 DOI: 10.1259/Bjr/78981552  0.361
2007 Anderson VM, Bartlett JW, Fox NC, Fisniku L, Miller DH. Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates. Journal of Neurology. 254: 1588-94. PMID 17940723 DOI: 10.1007/S00415-007-0599-3  0.341
2007 Pol LAvd, Flier WMvd, Korf ESC, Fox NC, Barkhof F, Scheltens P. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment Neurology. 69: 1491-1497. PMID 17923611 DOI: 10.1212/01.Wnl.0000277458.26846.96  0.423
2007 Barnes J, Lewis EB, Scahill RI, Bartlett JW, Frost C, Schott JM, Rossor MN, Fox NC. Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. Journal of Computer Assisted Tomography. 31: 581-7. PMID 17882036 DOI: 10.1097/Rct.0B013E31802F4139  0.355
2007 Ridha BH, Tozer DJ, Symms MR, Stockton KC, Lewis EB, Siddique MM, MacManus DG, Rossor MN, Fox NC, Tofts PS. Quantitative magnetization transfer imaging in Alzheimer disease. Radiology. 244: 832-7. PMID 17709831 DOI: 10.1148/Radiol.2443061128  0.401
2007 van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Archives of Neurology. 64: 1023-8. PMID 17620494 DOI: 10.1001/Archneur.64.7.1023  0.3
2007 Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, Rossor MN, Scheltens P, Fox NC. Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Archives of Neurology. 64: 849-54. PMID 17562933 DOI: 10.1001/Archneur.64.6.849  0.388
2007 Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. The American Journal of Psychiatry. 164: 916-21. PMID 17541051 DOI: 10.1176/Ajp.2007.164.6.916  0.459
2007 Smith SM, Rao A, De Stefano N, Jenkinson M, Schott JM, Matthews PM, Fox NC. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage. 36: 1200-6. PMID 17537648 DOI: 10.1016/J.Neuroimage.2007.04.035  0.406
2007 Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, ... ... Fox NC, et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. The Lancet. Neurology. 6: 501-12. PMID 17509485 DOI: 10.1016/S1474-4422(07)70109-6  0.407
2007 Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS. Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. Ajnr. American Journal of Neuroradiology. 28: 965-70. PMID 17494679  0.331
2007 Paviour DC, Price SL, Lees AJ, Fox NC. MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. Journal of Neurology. 254: 478-81. PMID 17401522 DOI: 10.1007/S00415-006-0396-4  0.37
2007 Whitwell JL, Sampson EL, Loy CT, Warren JE, Rossor MN, Fox NC, Warren JD. VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage. 35: 207-13. PMID 17240166 DOI: 10.1016/J.Neuroimage.2006.12.006  0.375
2007 Anderson VM, Fernando KT, Davies GR, Rashid W, Frost C, Fox NC, Miller DH. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 17: 61-8. PMID 17238871 DOI: 10.1111/J.1552-6569.2006.00081.X  0.358
2007 van de Pol LA, Barnes J, Scahill RI, Frost C, Lewis EB, Boyes RG, van Schijndel RA, Scheltens P, Fox NC, Barkhof F. Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration. Neuroimage. 34: 1036-41. PMID 17174572 DOI: 10.1016/J.Neuroimage.2006.10.033  0.332
2007 Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 68: 501-8. PMID 17065593 DOI: 10.1212/01.Wnl.0000244749.20056.D4  0.388
2007 Barnes J, Boyes RG, Lewis EB, Schott JM, Frost C, Scahill RI, Fox NC. Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral. Neurobiology of Aging. 28: 1657-63. PMID 16934913 DOI: 10.1016/J.Neurobiolaging.2006.07.008  0.368
2007 Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC. Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiology of Aging. 28: 20-8. PMID 16406154 DOI: 10.1016/J.Neurobiolaging.2005.11.012  0.419
2007 Schott JM, Fox NC. Structural imaging in the dementias Psychiatry. 6: 503-507. DOI: 10.1016/J.Mppsy.2007.09.006  0.468
Show low-probability matches.